Infections, IBD-co-morbidities

IBD_INFECTIONS

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints IBD_BACT_INTEST_INFECTIONS IBD_CMV IBD_TUBERCULOSIS	11677
6. Filter based on genotype QC (FinnGen only)	11677

Control definitions (FinnGen only)

Control exclude: IBD_COMORB

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	IBD_INFECTIONS
CONTROL_EXCLUDE	IBD_COMORB
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	IBD_BACT_INTEST_INFECTIONS\|IBD_CMV\|IBD_TUBERCULOSIS
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Infections, IBD-co-morbidities based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	11677	5835	5842
Unadjusted period prevalence (%)	2.28	1.99	2.58
Median age at first event (years)	57.27	53.74	60.80

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
5039: Matched controls
44524

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

7.4

323.0

1914

3380

A49.9

ICD-10 Finland

Bacterial infection, unspecified

9.6

323.0

837

907

N02BE01

ATC

paracetamol; systemic, rectal

4.2

323.0

4147

23327

UJF32

NOMESCO Finland

Coloscopy

5.4

323.0

1535

3348

A04.9

ICD-10 Finland

Bacterial intestinal infection, unspecified

356.1

323.0

512

GD1AA

NOMESCO Finland

Thorax X-ray examination

6.6

323.0

2505

5774

127

Kela drug reimbursment

Transplant complication

52.4

323.0

415

215

Kela drug reimbursment

Diabetes, non-insulin-treated

379.9

323.0

879

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

11.2

323.0

684

614

P01AB01

ATC

metronidazole; oral, rectal

4.0

323.0

2539

9038

N02AX02

ATC

tramadol; systemic, rectal

6.3

323.0

2189

4802

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

8.9

323.0

1739

2489

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

25.2

323.0

508

197

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

4.9

323.0

1647

4001

J01MA02

ATC

ciprofloxacin; systemic

4.1

323.0

2269

7416

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2050.1

323.0

1585

C03CA01

ATC

furosemide; systemic

9.1

323.0

1143

1388

J01MA12

ATC

levofloxacin; systemic

5.5

323.0

1203

2387

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

7.5

323.0

1077

1557

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

3.9

323.0

2001

6485

A10BA02

ATC

metformin; oral

38.5

323.0

772

208

103

Kela drug reimbursment

Diabetes, insulin-treated

330.2

323.0

915

A04.5

ICD-10 Finland

Campylobacter enteritis

224.5

323.0

585

A04.8

ICD-10 Finland

Other specified bacterial intestinal infections

162.8

323.0

767

A02BC02

ATC

pantoprazole; systemic

4.8

323.0

3392

13341

M17.1

ICD-10 Finland

Other primary gonarthrosis

16.2

323.0

576

352

M25.5

ICD-10 Finland

Pain in joint

5.1

323.0

1289

2800

N03AX16

ATC

pregabalin; oral

9.4

323.0

1200

1427

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

29.1

323.0

477

159

M79.6

ICD-10 Finland

Pain in limb

4.5

323.0

1538

3990

N02AJ06

ATC

codeine and paracetamol; systemic

3.9

323.0

1833

5749

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

7.1

323.0

956

1416

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

30.0

323.0

572

189

R50.9

ICD-10 Finland

Fever, unspecified

6.1

323.0

1095

1948

T90

ICPC

Diabetes non-insulin dependent

19.7

323.0

687

354

N03AX12

ATC

gabapentin; oral

15.7

323.0

725

472

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

49.2

323.0

712

148

AA1AD

NOMESCO Finland

CT of head and brain

9.8

323.0

1055

1165

TPH04

NOMESCO Finland

Cathetrisation of vein

5.3

323.0

1286

2687

A10AE04

ATC

insulin glargine; parenteral

143.4

323.0

390

H02AB06

ATC

prednisolone; systemic

4.5

323.0

2508

8018

J18.9

ICD-10 Finland

Pneumonia, unspecified

5.3

323.0

1218

2521

A07AA09

ATC

vancomycin; oral

170.1

323.0

550

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

68.1

323.0

464

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

3.7

323.0

2234

7911

G47.3

ICD-10 Finland

Sleep apnoea

20.7

323.0

896

460

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

75.2

318.9

378

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

32.0

318.4

442

133

SPAT1262

SPAT

Handing over of treatment supplies

9.1

312.9

718

795

C07AB07

ATC

bisoprolol; oral

3.6

299.7

1800

6003

M54.5

ICD-10 Finland

Low back pain

4.0

295.6

1435

3987

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

59.9

293.9

360

J01FF01

ATC

clindamycin; systemic

3.8

289.0

1567

4777

R4110

NOMESCO Finland

Physiotherapy

4.0

288.0

1395

3855

Z3226

NOMESCO Finland

Physiotherapist

5.4

285.1

987

1935

L04AA06

ATC

mycophenolic acid; systemic

47.8

285.1

363

WX408

NOMESCO Finland

General anesthesy, balanced

3.7

285.0

1562

4797

M48.0

ICD-10 Finland

Spinal stenosis

94.5

278.5

321

R06.0

ICD-10 Finland

Dyspnoea

4.7

278.0

1097

2476

WX002

NOMESCO Finland

Sedation and analgesia

4.9

275.8

1049

2276

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

36.6

275.2

370

H02AB04

ATC

methylprednisolone; systemic

5.4

274.0

935

1796

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

95.6

273.7

315

A02BC05

ATC

esomeprazole; systemic

3.2

271.8

1977

7494

G56.0

ICD-10 Finland

Carpal tunnel syndrome

15.8

271.2

471

288

ZXA00

NOMESCO Finland

Right side

4.3

266.2

1177

2961

Z01.8

ICD-10 Finland

Other specified special examinations

4.4

263.5

1107

2647

B25.8

ICD-10 Finland

Other cytomegaloviral diseases

1230.7

260.3

264

A02BC01

ATC

omeprazole; systemic

3.9

257.3

1295

3651

N02AA05

ATC

oxycodone; systemic

7.0

256.3

701

1007

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

101.3

255.2

292

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

15.8

253.8

441

269

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

8.6

253.6

601

692

ZXD05

NOMESCO Finland

Urgent procedure

3.2

251.3

1744

6312

R51.80

ICD-10 Finland

Headache

5.8

250.9

795

1386

S06.0

ICD-10 Finland

Concussion

15.5

249.8

437

271

M54.4

ICD-10 Finland

Lumbago with sciatica

6.7

242.4

683

1019

S18

ICPC

Laceration/cut

3.1

239.2

1799

6835

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

2.9

238.9

2129

9045

A07EC01

ATC

sulfasalazine; oral, rectal

17.5

238.7

398

217

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

152.4

237.8

262

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

59.0

236.1

290

C08CA01

ATC

amlodipine; oral

3.6

235.4

1297

3905

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

11.4

235.3

472

398

M04AA01

ATC

allopurinol; systemic

8.9

234.3

541

593

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

13.9

233.6

428

296

A10BH01

ATC

sitagliptin; oral

556.8

233.5

241

B01AB05

ATC

enoxaparin; parenteral

3.5

232.3

1321

4072

ACC51

NOMESCO Finland

Release of median nerve

442.8

230.8

240

R5140

NOMESCO Finland

Monitoring the use of the aid

19.4

230.0

369

180

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

46.6

229.8

294

B25.9

ICD-10 Finland

Cytomegaloviral disease, unspecified

+∞

229.3

229

ZXE10

NOMESCO Finland

More than one and less than three hours

3.0

228.2

1717

6481

Z3231

NOMESCO Finland

Registered nurse

3.4

227.5

1363

4366

A02BC03

ATC

lansoprazole; oral

3.5

227.5

1311

4075

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2031.1

227.0

229

J01DB01

ATC

cefalexin; oral

3.0

226.6

4058

25850

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

4.6

225.0

888

1965

ZX120

NOMESCO Finland

Intravenous

5.9

224.4

697

1176

L04AX01

ATC

azathioprine; systemic

9.5

223.8

495

502

E11

ICD-10 Finland

Type 2 diabetes mellitus

17.1

223.6

376

209

TK800

NOMESCO Finland

Hemodialysis

30.6

223.2

313

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

6.7

222.4

626

927

A10AE05

ATC

insulin detemir; parenteral

199.5

219.2

237

XF400

NOMESCO Finland

ECG with 12 standard connections

4.8

218.8

822

1724

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

417.5

217.8

227

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

4.9

216.6

804

1664

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

7.3

216.5

569

763

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

3.9

215.6

1057

2860

L04AD01

ATC

ciclosporin; systemic

26.2

215.5

315

113

UJF30

NOMESCO Finland

Ileoscopy through colon

5.7

214.9

686

1194

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

25.1

213.8

316

118

R03AC02

ATC

salbutamol; inhalant

2.6

213.0

2544

12591

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

50.7

211.9

267

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

13.6

211.6

390

272

ZXA05

NOMESCO Finland

Left side

3.8

209.3

1051

2895

I10

ICD-10 Finland

Essential (primary) hypertension

2.7

208.6

1931

8214

P01BA02

ATC

hydroxychloroquine; oral

23.3

208.3

315

127

L28

ICPC

Limited function/disability (L)

7.7

207.6

526

666

R07.4

ICD-10 Finland

Chest pain, unspecified

3.6

207.3

1106

3200

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

4.7

204.7

783

1666

N05CF01

ATC

zopiclone; oral

3.1

203.7

1402

4908

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

5.9

203.4

632

1060

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

7.3

201.4

526

696

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

+∞

201.0

201

Z94.0

ICD-10 Finland

Kidney transplant status

62.7

200.6

244

NF1AA

NOMESCO Finland

Hip X-ray examination

22.4

197.5

302

126

JN3BD

NOMESCO Finland

Extensive abdominal CT

5.0

196.7

702

1383

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

3.3

195.8

1174

3704

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

8.4

194.8

465

534

M01AH05

ATC

etoricoxib; oral

2.5

194.6

2629

13663

N06AX21

ATC

duloxetine; oral

6.8

191.4

530

761

M19.0

ICD-10 Finland

Primary arthrosis of other joints

19.3

191.2

307

149

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

5.5

190.3

628

1129

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

+∞

190.0

190

A28

ICPC

Limited function/disability NOS

8.0

188.5

464

559

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

3.8

186.6

916

2451

C10AA01

ATC

simvastatin; oral

3.1

186.6

1260

4313

M54.9

ICD-10 Finland

Dorsalgia, unspecified

7.3

186.0

486

641

M13.9

ICD-10 Finland

Arthritis, unspecified

17.7

183.5

304

161

205

Kela drug reimbursment

Chronic hypertension

4.1

183.3

807

1957

H02AB07

ATC

prednisone; oral

4.4

182.8

748

1691

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

166.2

181.7

199

N06AX11

ATC

mirtazapine; oral

2.8

181.2

1443

5493

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

+∞

180.9

181

ZXE00

NOMESCO Finland

One hour or less

2.6

180.9

1892

8461

M16.1

ICD-10 Finland

Other primary coxarthrosis

30.5

180.4

253

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

14.0

180.1

327

219

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

3.2

178.5

1153

3808

M75.1

ICD-10 Finland

Rotator cuff syndrome

4.0

178.4

821

2069

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

7.5

178.2

456

582

R10.1

ICD-10 Finland

Pain localized to upper abdomen

3.9

178.2

834

2134

Z2446

NOMESCO Finland

Social worker

6.6

178.0

498

723

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

86.6

177.7

207

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

14.6

177.0

316

203

A11CC03

ATC

alfacalcidol; systemic

25.2

177.0

261

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

1707.5

175.7

178

ZXD10

NOMESCO Finland

Scheduled procedure

2.6

174.6

1752

7621

A06AD11

ATC

lactulose; oral

5.2

173.5

595

1113

ZXE20

NOMESCO Finland

More than three and less than five hours

4.3

173.4

733

1705

R53

ICD-10 Finland

Malaise and fatigue

3.7

173.0

886

2444

Z01.0

ICD-10 Finland

Examination of eyes and vision

4.3

172.8

734

1714

N06AA09

ATC

amitriptyline; systemic

8.6

171.2

400

441

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

72.2

171.1

204

A46

ICD-10 Finland

Erysipelas

4.8

170.1

629

1277

J01AA02

ATC

doxycycline; systemic

2.4

169.7

3636

23099

G44.2

ICD-10 Finland

Tension-type headache

5.6

169.2

545

946

SPAT1263

SPAT

Sampling

2.5

169.0

1851

8410

A06AC01

ATC

ispaghula (psylla seeds); oral

3.2

168.5

1044

3330

T89

ICPC

Diabetes insulin dependent

116.1

168.3

190

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

16.6

167.8

284

159

R42

ICD-10 Finland

Dizziness and giddiness

3.9

167.3

789

2024

A10BK03

ATC

empagliflozin; oral

319.5

166.9

176

Z49.1

ICD-10 Finland

Extracorporeal dialysis

60.1

165.8

203

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

11.3

165.8

332

275

JN3AD

NOMESCO Finland

Abdominal CT examination

6.0

164.3

498

801

X59

ICD-10 Finland

Exposure to unspecified factor

3.5

162.6

885

2552

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

227.2

162.1

174

J01FA06

ATC

roxithromycin; oral

2.4

162.0

1921

9051

C10AA05

ATC

atorvastatin; oral

2.9

162.0

1209

4367

A41.9

ICD-10 Finland

Sepsis, unspecified

14.6

162.0

289

185

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

42.2

161.9

211

WX110

NOMESCO Finland

Local anesthesy

2.3

161.7

3402

21127

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

12.6

161.3

307

228

L03

ICPC

Low back symptom/complaint

3.3

159.8

966

3015

R11

ICD-10 Finland

Nausea and vomiting

6.3

159.6

464

706

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

5.0

159.4

567

1100

M03BX02

ATC

tizanidine; oral

2.2

158.8

2881

16620

J45.9

ICD-10 Finland

Asthma, unspecified

3.7

158.6

795

2141

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

9.0

158.1

359

376

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

134.1

157.9

176

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

2.5

157.0

1685

7505

A02BA02

ATC

ranitidine; systemic

3.6

156.9

816

2264

UGC12

NOMESCO Finland

Flexible bronchoscopy

6.9

156.9

423

580

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

9.6

155.9

341

334

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

2.2

155.7

2572

14152

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

4.2

155.4

668

1568

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

7.8

154.5

383

463

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

58.0

154.4

190

WX892

NOMESCO Finland

Monitored bed care

6.3

154.2

449

684

B03XA02

ATC

darbepoetin alfa; parenteral

32.5

153.7

212

N05BA04

ATC

oxazepam; oral

2.9

153.6

1126

4002

M01AE02

ATC

naproxen; oral, rectal

2.2

152.5

2575

14259

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

3.8

152.4

733

1902

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

+∞

151.7

152

SPAT1153

SPAT

Removal of sutures

2.8

149.7

1185

4413

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

9.7

149.2

324

313

J01MA14

ATC

moxifloxacin; systemic

4.9

147.4

533

1049

A12AA04

ATC

calcium carbonate; oral

40.2

146.7

193

D64.9

ICD-10 Finland

Anaemia, unspecified

5.9

146.6

447

721

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

8.1

145.9

354

413

J01.0

ICD-10 Finland

Acute maxillary sinusitis

2.9

145.7

1078

3838

SPAT1148

SPAT

Treatment of chronic ulcer or burn

5.1

145.7

506

952

N05AH04

ATC

quetiapine; oral

3.4

145.5

829

2458

A10AA02

ATC

179.9

145.0

158

XCK10

NOMESCO Finland

Photography of fundus of eye

7.0

144.9

387

522

M01AE03

ATC

ketoprofen; systemic, rectal

2.5

144.8

1493

6452

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

29.7

144.8

204

L17

ICPC

Foot/toe symptom/complaint

3.1

144.5

954

3146

NFB30

NOMESCO Finland

Primary total prosthetic replacement of hip joint not using cement

123.1

144.3

162

M03BC01

ATC

orphenadrine (citrate); systemic

2.9

143.6

1074

3845

K29.3

ICD-10 Finland

Chronic superficial gastritis

15.5

142.8

248

148

N17.9

ICD-10 Finland

Acute renal failure, unspecified

15.8

142.7

246

144

SPAT1229

SPAT

Assessment of need for aid

11.9

142.2

278

218

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

198.9

141.4

153

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

7.4

141.3

361

456

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

70.2

141.2

169

J01DA01

ATC

[U] cefalexin; systemic

2.1

141.0

2920

17449

B01AC04

ATC

clopidogrel; oral

6.1

140.9

418

650

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

2.2

140.4

2270

12161

TPH07

NOMESCO Finland

Cathetrisation of artery

4.7

140.1

528

1083

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

174.0

140.1

153

A10AA01

ATC

227.4

139.7

150

M01AH01

ATC

celecoxib; oral (coxibs)

3.9

139.2

654

1655

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

5.7

138.4

432

716

WX320

NOMESCO Finland

Spinalanesthesy

3.4

137.6

783

2313

M01AB05

ATC

diclofenac; systemic, rectal

2.1

136.9

2963

17939

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

6.0

136.7

410

646

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

5.0

136.4

484

930

D11

ICPC

Diarrhoea

3.7

136.3

673

1775

A07EC02

ATC

mesalazine; oral, rectal

4.9

136.0

485

937

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

7.1

135.8

357

470

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

65.1

135.6

164

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

8.1

135.6

327

377

Z2221

NOMESCO Finland

Medical doctor

2.5

135.0

1388

5948

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

320.1

134.6

142

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.8

133.6

1057

3898

N18.8

ICD-10 Finland

Other chronic renal failure

25.3

133.3

196

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

4.0

133.3

605

1482

NE1AA

NOMESCO Finland

Pelvis X-ray examination

14.6

131.1

233

147

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

10.9

130.5

266

227

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

11.4

130.0

259

211

N06AX16

ATC

venlafaxine; oral

3.5

128.9

679

1883

N06AB04

ATC

citalopram; systemic

2.9

128.6

946

3324

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

18.8

128.3

207

101

F32.9

ICD-10 Finland

Depressive episode, unspecified

3.7

127.9

641

1706

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

+∞

127.7

128

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

12.1

127.3

246

188

N05CD07

ATC

temazepam; oral

4.7

127.0

470

943

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

72.4

126.7

151

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

60.8

126.1

154

G40.9

ICD-10 Finland

Epilepsy, unspecified

205.5

125.9

136

R60.0

ICD-10 Finland

Localized oedema

5.5

124.8

402

690

N05BA01

ATC

diazepam; systemic, rectal

3.9

124.7

582

1457

R03BB04

ATC

tiotropium bromide; inhalant

6.0

124.6

375

592

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

+∞

123.7

124

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

5.7

123.5

387

642

A02BD07

ATC

lansoprazole, amoxicillin and clarithromycin; systemic

6.0

123.3

370

582

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

24.8

123.2

182

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

4.8

123.1

447

878

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

3.1

122.8

775

2453

M10.9

ICD-10 Finland

Gout, unspecified

13.8

122.1

222

148

TPX10

NOMESCO Finland

Implantation of vascular injection port

8.0

122.0

297

347

L04AA01

ATC

[U] ciclosporin; systemic

35.0

121.9

165

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

6.2

121.5

353

532

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

3.8

121.4

585

1503

L15

ICPC

Knee symptom/complaint

3.3

121.4

701

2080

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

4.0

121.2

546

1323

137

Kela drug reimbursment

Uraemia requiring dialysis

76.4

120.9

143

A03FA01

ATC

metoclopramide; systemic, rectal

2.7

120.9

1010

3823

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

234.0

120.4

129

C07AB02

ATC

metoprolol; systemic

3.7

120.2

598

1578

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

8.4

119.3

280

308

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

7.0

119.1

316

420

XW000

NOMESCO Finland

Bone marrow biopsy

8.1

118.6

286

329

S97

ICPC

Chronic ulcer skin

11.0

118.5

240

202

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

3.6

118.3

605

1632

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

14.1

118.2

213

139

J02AC01

ATC

fluconazole; systemic

2.1

118.1

1924

10111

M01AX17

ATC

nimesulide; oral

2.9

117.9

856

2968

A10BB12

ATC

glimepiride; oral

1084.0

117.6

120

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

17.3

117.5

195

103

B01AA03

ATC

warfarin; systemic

4.1

117.3

505

1173

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

191.6

117.1

127

M01AC06

ATC

meloxicam; systemic, rectal

2.3

116.7

1372

6212

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

13.8

116.7

212

141

SPAT1255

SPAT

Intravenous administration of medicine

6.2

116.5

340

515

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

4.7

116.4

433

871

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

3.3

115.5

661

1943

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

7.3

115.3

298

381

H02AB09

ATC

hydrocortisone; systemic

12.8

115.0

216

155

A10AE06

ATC

insulin degludec; parenteral

277.9

114.8

122

TAB00

NOMESCO Finland

Lumbar puncture

10.9

114.3

232

196

I50.9

ICD-10 Finland

Heart failure, unspecified

7.0

114.3

302

399

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

81.0

114.2

134

N18.0

ICD-10 Finland

End-stage renal disease

53.7

114.1

142

A10BH05

ATC

linagliptin; oral

+∞

113.6

114

E66.01

ICD-10 Finland

Obesity due to excess calories

6.0

113.3

337

523

WX722

NOMESCO Finland

PEEP

21.3

113.2

175

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

8.2

113.1

271

308

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

+∞

112.6

113

A15.0

ICD-10 Finland

Tuberculosis of lung, confirmed by sputum microscopy with or without culture

+∞

112.6

113

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

216.9

111.5

120

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

3.6

111.4

556

1466

A07EA06

ATC

budesonide; oral, local oral

6.6

110.3

307

436

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

9.5

109.8

240

233

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

5.7

109.8

341

558

K59.1

ICD-10 Finland

Functional diarrhoea

6.8

109.7

298

409

01102

ICD-8 Finland

Pulmonary tuberculosis, Non cavernosa

+∞

109.6

110

WZB00

NOMESCO Finland

Telephone receipt or other advice

2.3

109.5

1349

6214

ZXA10

NOMESCO Finland

Bilateral

3.0

109.5

711

2281

C09AA05

ATC

ramipril; oral

3.0

109.2

719

2329

SPAT1254

SPAT

Administration of medicine

3.6

109.1

544

1432

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

23.3

109.1

164

N03AG01

ATC

valproic acid; systemic, rectal

6.1

108.8

320

489

N03AF02

ATC

oxcarbazepine; oral

73.1

108.5

129

L88

ICPC

Rheumatoid/seropositive arthritis

77.3

108.5

128

N03AE01

ATC

clonazepam; systemic

7.3

108.2

279

355

A07AA02

ATC

nystatin; oral

6.1

108.0

319

490

UKC02

NOMESCO Finland

Cystoscopy

3.5

107.9

559

1518

A01

ICPC

Pain general/multiple sites

6.3

107.6

310

461

J01FA10

ATC

azithromycin; systemic

1.9

107.5

2877

18118

V03AE01

ATC

polystyrene sulfonate; oral

76.7

107.5

127

C09AA02

ATC

enalapril; systemic

3.3

107.5

606

1756

C08CA13

ATC

lercanidipine; oral

4.5

107.5

414

861

M79.0

ICD-10 Finland

Rheumatism, unspecified

54.8

107.2

133

H3603, E103

ICD-10 Finland

+∞

106.6

107

E66.8

ICD-10 Finland

Other obesity

8.3

105.9

250

277

WW500

NOMESCO Finland

Blood transfusion

6.0

105.9

315

488

SPAT1301

SPAT

No procedures

2.3

105.6

1160

5041

ABC16

NOMESCO Finland

Microsurgical excision of lumbar intervertebral disc displacement

+∞

105.6

106

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

3.4

105.5

579

1642

JN4AD

NOMESCO Finland

Body CT examination

4.2

104.6

437

983

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

12.3

104.2

199

148

TGC00

NOMESCO Finland

Bronchial lavation

12.7

103.7

195

140

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

106.6

103.7

118

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

34.3

103.1

140

JN4BD

NOMESCO Finland

Extensive body CT

3.4

102.8

557

1564

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

+∞

102.6

103

J01FA09

ATC

clarithromycin; systemic

2.1

102.5

1504

7450

SPAT1222

SPAT

Counselling/guidance promoting independent living

3.9

102.4

472

1160

WX780

NOMESCO Finland

Remote monitoring CPAP

322.5

102.4

108

M01AH02

ATC

rofecoxib; oral

4.2

102.2

422

938

SPAT1216

SPAT

Assessment of functional ability

4.3

100.7

412

908

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

927.0

100.7

103

M02AA07

ATC

piroxicam; topical

2.2

100.4

1285

5983

M79.1

ICD-10 Finland

Myalgia

3.6

99.8

498

1308

I25.1

ICD-10 Finland

Atherosclerotic heart disease

3.6

99.6

505

1344

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

7.2

99.5

259

334

L13

ICPC

Hip symptom/complaint

4.0

99.1

433

1014

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

462.4

99.0

103

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

3.9

98.8

449

1089

E0000UV

ATC

2.0

98.7

1786

9607

M05BA04

ATC

alendronic acid; oral

7.7

98.5

244

292

K51.5

ICD-10 Finland

Left sided colitis

5.9

98.3

296

465

Z3229

NOMESCO Finland

Other healthcare associate professional

4.7

97.5

362

723

R06AE07

ATC

cetirizine; oral

1.9

97.0

2029

11509

M03BC51

ATC

orphenadrine, combinations; systemic

2.2

96.5

1207

5546

G43.9

ICD-10 Finland

Migraine, unspecified

8.1

96.4

231

262

L04AA13

ATC

leflunomide; oral

137.8

96.3

107

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

69.3

96.1

115

WW200

NOMESCO Finland

Immunization

7.3

96.0

247

313

B05DA

ATC

Isotonic solutions

78.5

96.0

113

C08CA02

ATC

felodipine; oral

5.9

95.8

287

448

H04AA01

ATC

glucagon; nasal, parenteral

136.5

95.4

106

L08

ICPC

Shoulder symptom/complaint

2.9

95.2

652

2153

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

12.9

94.9

177

125

M01AX05

ATC

glucosamine; oral

3.9

94.7

423

1009

J01CA04

ATC

amoxicillin; systemic

2.0

94.5

3876

27838

WX723

NOMESCO Finland

CPAP therapy

119.4

94.2

106

R05

ICPC

Cough

2.4

94.2

907

3659

M70.6

ICD-10 Finland

Trochanteric bursitis

4.8

93.8

340

662

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

2.2

93.6

1150

5228

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

3.2

93.4

565

1713

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

88.6

93.1

108

R03AK06

ATC

salmeterol and fluticasone; inhalant

3.1

93.0

568

1734

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

3.8

92.6

439

1102

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.6

91.9

795

3022

X58

ICD-10 Finland

Exposure to other specified factors

2.9

91.8

625

2053

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

32.6

91.7

126

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

5.2

91.7

309

555

Z49.2

ICD-10 Finland

Other dialysis

66.2

91.4

110

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

6.4

91.2

257

370

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

5.9

91.2

274

429

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

5.0

90.9

314

580

C01DA14

ATC

isosorbide mononitrate; oral

5.8

90.6

275

436

C02AC05

ATC

moxonidine; oral

12.1

90.6

174

131

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

4.8

90.2

328

640

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.8

90.0

2541

15873

XF402

NOMESCO Finland

ECG with work load test

3.9

89.8

412

1005

N80.3

ICD-10 Finland

Endometriosis of pelvic peritoneum

282.4

89.6

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

3.8

89.6

418

1035

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

4.9

89.4

316

598

N06AB10

ATC

escitalopram; oral

2.3

88.7

935

3936

R02

ICPC

Shortness of breath/dyspnoea

3.7

88.7

424

1071

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

+∞

88.6

M54.3

ICD-10 Finland

Sciatica

9.1

88.6

197

N06CA01

ATC

amitriptyline and psycholeptics; systemic

4.3

88.5

362

795

M45

ICD-10 Finland

Ankylosing spondylitis

112.5

88.4

100

WZC30

NOMESCO Finland

Teaching

2.9

88.3

615

2049

R05

ICD-10 Finland

Cough

2.6

88.2

762

2889

C03DA01

ATC

spironolactone; oral

4.3

88.1

357

777

Z50.1

ICD-10 Finland

Other physical therapy

8.7

87.9

201

211

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

807.7

87.7

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

+∞

87.6

D07AC01

ATC

betamethasone; topical

2.0

87.5

1415

7201

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

4.4

87.5

348

744

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

51.7

87.1

109

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

3.9

86.8

395

956

D01

ICPC

Abdominal pain/cramps general

3.2

86.7

513

1529

SPAT1310

SPAT

Counselling related to known health issue

2.1

86.5

1193

5679

R4120

NOMESCO Finland

Occupational therapy

6.8

86.3

232

313

SAA01

NOMESCO Finland

Simple examination of mouth

1.8

86.0

3347

23098

M20.1

ICD-10 Finland

Hallux valgus (acquired)

9.1

85.9

191

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

5.5

85.8

275

466

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

53.1

85.1

106

M54.2

ICD-10 Finland

Cervicalgia

5.5

85.1

272

459

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

2.0

85.0

1456

7563

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

6.8

84.3

227

307

SAA03

NOMESCO Finland

Extended examination of mouth

1.9

84.3

1860

10601

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

5.0

84.1

291

538

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.8

84.1

2217

13419

Z71.8

ICD-10 Finland

Other specified counselling

2.2

84.0

1027

4627

WX872

NOMESCO Finland

Intensive care

5.4

83.8

270

460

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

771.1

83.7

M54.1

ICD-10 Finland

Radiculopathy

14.8

83.7

147

J05AB01

ATC

aciclovir; systemic

2.2

83.0

960

4212

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

26.4

83.0

120

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

5.5

82.9

263

440

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

4.8

82.3

294

562

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

2.1

82.1

1219

5965

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

15.1

82.0

143

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

+∞

81.6

0084F

ICD-9 Finland

Intestinal infections due to other organisms, Other specified bacteria[ENTERITIS CLOSTRIDIUM DIFFICILE]

+∞

81.6

K02.1

ICD-10 Finland

Caries of dentine

1.8

81.4

2717

17680

R20.2

ICD-10 Finland

Paraesthesia of skin

5.0

81.2

280

515

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

43.0

81.2

105

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

5.4

81.0

260

441

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

20.1

81.0

127

A10BD07

ATC

metformin and sitagliptin; systemic

743.7

80.8

A15.1

ICD-10 Finland

Tuberculosis of lung, confirmed by culture only

+∞

80.6

M43.1

ICD-10 Finland

Spondylolisthesis

24.4

80.5

119

N03AX14

ATC

levetiracetam; systemic

33.9

80.2

109

SPAT1260

SPAT

Consultation of another employee

2.6

80.2

644

2333

Z49.0

ICD-10 Finland

Preparatory care for dialysis

31.3

80.2

111

UJD02

NOMESCO Finland

Gastroscopy

6.2

80.1

232

346

A02BD03

ATC

lansoprazole, amoxicillin and metronidazole; systemic

4.2

80.1

328

720

A03

ICPC

Fever

2.4

79.9

816

3366

C09CA01

ATC

losartan; oral

2.4

79.7

772

3099

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

4.4

79.7

314

664

M79.7

ICD-10 Finland

Fibromyalgia

18.7

79.6

128

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

3.7

79.3

379

955

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

370.5

79.2

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

13.6

79.2

144

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

12.4

79.1

150

110

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

114.2

78.9

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

725.4

78.8

B05DB

ATC

Hypertonic solutions

82.7

78.7

SPAT1249

SPAT

Treatment-related counselling outside office

1.9

78.7

1514

8168

J05AB11

ATC

valaciclovir; oral

2.6

78.6

643

2351

M53.1

ICD-10 Finland

Cervicobrachial syndrome

3.4

78.5

413

1125

A04.6

ICD-10 Finland

Enteritis due to Yersinia enterocolitica

190.7

78.4

L30.9

ICD-10 Finland

Dermatitis, unspecified

2.4

78.4

737

2911

N30.0

ICD-10 Finland

Acute cystitis

2.9

78.4

536

1758

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

7.1

78.3

203

260

N80.1

ICD-10 Finland

Endometriosis of ovary

249.3

77.8

A10BJ06

ATC

semaglutide; parenteral

+∞

77.6

01107

ICD-8 Finland

Pulmonary tuberculosis, Suspecta

+∞

77.6

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

+∞

77.6

GD1AD

NOMESCO Finland

Thorax CT examination

5.9

77.6

231

357

N03AF01

ATC

carbamazepine; oral, rectal

8.5

77.1

179

193

SPAT1104

SPAT

Monitoring of emergency patient

4.7

77.1

281

549

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.9

77.0

1593

8804

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

46.4

76.9

N05CF02

ATC

zolpidem; oral

2.4

76.9

756

3051

7227C

ICD-9 Finland

Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[SYNDROMA ISCHIADICUM]

+∞

76.6

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

+∞

76.6

TKC20

NOMESCO Finland

Catheterisation of bladder

4.9

76.5

272

517

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

3.9

76.3

338

797

NHK30

NOMESCO Finland

Osteotomy or rotation osteotomy of first metatarsal or tarsal bone

356.7

76.2

E66.00

ICD-10 Finland

Metabolic syndrome

7.3

76.1

194

242

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

127.2

76.1

R56.8

ICD-10 Finland

Other and unspecified convulsions

6.1

75.8

220

329

E10

ICD-10 Finland

Type 1 diabetes mellitus

243.0

75.8

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

8.8

75.7

171

176

J45.1

ICD-10 Finland

Nonallergic asthma

4.3

75.6

307

668

B03XA01

ATC

erythropoietin; parenteral

52.8

75.5

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

12.2

75.5

144

107

L86

ICPC

Back syndrome with radiating pain

7.7

75.4

185

218

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

4.0

75.3

324

744

K92.1

ICD-10 Finland

Melaena

6.0

75.2

221

336

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

4.0

74.2

325

758

R52.2

ICD-10 Finland

Other chronic pain

11.8

74.2

144

111

C07AA05

ATC

propranolol; systemic

2.3

74.2

813

3461

J01EA01

ATC

trimethoprim; systemic

2.2

74.1

942

4291

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

2.2

73.8

937

4266

ZXE30

NOMESCO Finland

More than five and less than seven hours

4.6

73.7

275

550

L01

ICPC

Neck symptom/complaint

2.9

73.5

497

1616

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

24.0

73.4

109

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

4.5

73.2

277

562

L12

ICPC

Hand/finger symptom/complaint

2.8

73.2

542

1865

R01AD09

ATC

mometasone; nasal

1.8

73.1

1972

11851

H04.10

ICD-10 Finland

Dry eye syndrome

3.3

72.8

409

1169

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

+∞

72.6

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

+∞

72.6

R4190

NOMESCO Finland

Nutritional therapy

5.3

72.4

237

411

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

4.0

72.4

316

735

K30

ICD-10 Finland

Functional dyspepsia

3.1

72.3

431

1285

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

3.6

72.1

358

929

V03AE02

ATC

sevelamer; oral

83.8

72.1

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

4.3

72.0

288

617

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

29.3

71.9

101

T36

ICD-10 Finland

Poisoning by systemic antibiotics

5.2

71.7

238

419

XG466

NOMESCO Finland

Sleep oxymetry

16.3

71.7

121

A10BK01

ATC

dapagliflozin; oral

53.3

71.6

N06AB03

ATC

fluoxetine; oral

2.8

71.5

529

1818

K04.5

ICD-10 Finland

Chronic apical periodontitis

2.0

71.4

1082

5296

A04AA01

ATC

ondansetron; systemic, rectal

3.5

71.4

366

975

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

333.9

71.3

B01AB10

ATC

tinzaparin; parenteral

3.8

71.2

329

804

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

12.3

71.2

135

WX402

NOMESCO Finland

General anaesthesia

2.2

71.1

823

3587

XA800

NOMESCO Finland

Neuropsychological investigation

8.9

71.0

160

164

UJF92

NOMESCO Finland

Capsular endoscopy

8.8

70.9

161

167

R03DC03

ATC

montelukast; oral

2.4

70.7

696

2803

KA1AE

NOMESCO Finland

Kidney ultrasound examination

9.9

70.7

150

138

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

3.3

70.3

383

1069

M54.6

ICD-10 Finland

Pain in thoracic spine

4.7

70.3

257

503

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

118.0

70.3

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

47.0

70.1

B01AF01

ATC

rivaroxaban; oral

4.5

70.0

269

554

R03AK07

ATC

formoterol and budesonide; inhalant

2.2

69.8

839

3717

N03AX09

ATC

lamotrigine; oral

5.4

69.8

225

383

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

5.9

69.4

208

324

SPAT1097

SPAT

Recording of ECG

3.0

69.3

443

1384

XCW99

NOMESCO Finland

Other investigative procedure of eye

3.4

69.3

366

997

E86

ICD-10 Finland

Volume depletion

13.8

69.2

125

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

3.8

69.1

318

774

TDM10

NOMESCO Finland

Puncture of maxillary antrum

5.3

69.0

225

388

G04CA02

ATC

tamsulosin; oral

2.5

69.0

602

2271

NA1AD

NOMESCO Finland

Cervical spine CT examination

9.1

68.9

153

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

14.8

68.6

120

I48

ICD-10 Finland

Atrial fibrillation and flutter

3.0

68.3

443

1398

H03AA01

ATC

levothyroxine sodium; systemic

2.2

68.3

806

3539

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

72.7

68.3

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

4.3

68.2

276

598

RD210

NOMESCO Finland

10.8

68.2

138

116

M47.82

ICD-10 Finland

Other spondylosis, cervical region

23.9

68.1

101

G56.2

ICD-10 Finland

Lesion of ulnar nerve

21.0

68.0

105

M47.9

ICD-10 Finland

Spondylosis, unspecified

50.8

67.9

177

Kela drug reimbursment

Insulin glargine 300 U / ml

625.3

67.8

WX704

NOMESCO Finland

Intubation

3.6

67.8

334

861

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.7

67.8

2406

15589

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

6.0

67.7

198

299

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

13.5

67.7

123

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

+∞

67.7

L04AB04

ATC

adalimumab; parenteral

14.8

67.4

118

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

7.9

67.3

163

188

A04

ICPC

Weakness/tiredness general

3.0

67.2

440

1396

I50.0

ICD-10 Finland

Congestive heart failure

8.4

67.2

156

168

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.9

67.1

441

1404

WX882

NOMESCO Finland

High dependency care

8.1

66.9

159

178

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

17.9

66.9

109

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

53.2

66.8

C10AX09

ATC

ezetimibe; oral

3.7

66.7

314

779

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

10.6

66.7

136

116

J20

ICD-10 Finland

Acute bronchitis

3.3

66.7

375

1071

XF600

NOMESCO Finland

Bloodpressure measurement

4.2

66.6

270

586

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

4.0

66.4

284

648

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

3.5

66.4

341

909

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

86.3

66.3

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

4.2

66.2

269

585

R05FB02

ATC

cough suppressants and expectorants

1.8

66.2

1414

7814

K51.8

ICD-10 Finland

Other ulcerative colitis

9.0

65.9

147

148

AN1

Coronary angiography

4.0

65.7

281

641

NF1DA

NOMESCO Finland

X-ray of hips

110.5

65.4

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

24.7

65.3

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.9

65.1

434

1394

R52.9

ICD-10 Finland

Pain, unspecified

3.8

65.0

303

745

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

3.8

65.0

301

736

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

3.1

65.0

394

1185

A10BJ02

ATC

liraglutide; parenteral

208.8

65.0

R07.3

ICD-10 Finland

Other chest pain

3.5

64.9

327

858

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

+∞

64.7

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

+∞

64.7

N19

ICD-10 Finland

Unspecified kidney failure

12.9

64.7

120

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

75.7

64.4

A05AA02

ATC

ursodeoxycholic acid; oral

6.9

64.1

170

225

M22.4

ICD-10 Finland

Chondromalacia patellae

18.0

64.0

104

XG410

NOMESCO Finland

Flow-volume spirometry

5.8

63.9

192

300

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

12.3

63.8

121

ZXD20

NOMESCO Finland

Day surgery

2.6

63.7

510

1832

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

+∞

63.7

212

Kela drug reimbursment

Gout

+∞

63.7

NDM40

NOMESCO Finland

Discission of sheath of tendon of wrist or hand

127.1

63.6

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

8.7

63.3

144

150

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

9.5

63.3

137

131

L90

ICPC

Osteoarthrosis of knee

10.4

63.2

130

113

W19

ICD-10 Finland

Unspecified fall

3.4

62.8

331

899

WZA90

NOMESCO Finland

Other doctors statement

2.0

62.8

948

4603

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

42.7

62.7

N05BA12

ATC

alprazolam; oral

2.8

62.6

434

1427

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

67.3

62.6

NHQ40

NOMESCO Finland

Amputation of toe

44.8

62.5

A41.8

ICD-10 Finland

Other specified sepsis

13.1

62.5

115

R03BA02

ATC

budesonide; inhalant

2.2

62.4

710

3051

B99

ICD-10 Finland

Other and unspecified infectious diseases

9.9

62.4

132

121

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

47.2

62.3

H25.1

ICD-10 Finland

Senile nuclear cataract

2.9

62.2

408

1295

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

4.4

62.1

244

513

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

570.8

61.9

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

3.5

61.9

313

823

R31

ICD-10 Finland

Unspecified haematuria

3.4

61.8

324

877

NH3FA

NOMESCO Finland

Weight-bearing X-ray of foot

61.0

61.8

D06

ICPC

Abdominal pain localized other

3.3

61.7

334

926

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

+∞

61.7

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

+∞

61.7

M01AB55

ATC

diclofenac, combinations; oral

5.5

61.7

194

321

196

Kela drug reimbursment

Paricalcitol and cinacalcet

72.7

61.6

T86.0

ICD-10 Finland

Bone-marrow transplant rejection

104.4

61.6

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

288.2

61.4

R13

ICD-10 Finland

Dysphagia

4.6

61.3

229

458

M19.1

ICD-10 Finland

Post-traumatic arthrosis of other joints

49.3

61.2

K59.09

ICD-10 Finland

Constipation, unspecified

4.8

61.2

216

407

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

3.6

61.1

296

752

SPAT1211

SPAT

Application of soft bandage

3.4

61.0

318

856

C10AC01

ATC

colestyramine; oral

8.2

61.0

143

157

EBA00

NOMESCO Finland

Extraction of tooth

1.8

60.8

1387

7787

P20

ICPC

Memory disturbance

6.5

60.5

167

234

N04BC05

ATC

pramipexole; oral

5.4

60.4

193

325

ZX108

NOMESCO Finland

Inhalation

20.9

60.2

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.9

60.2

1160

6153

R96

ICPC

Asthma

3.4

60.2

321

880

C09CA06

ATC

candesartan; oral

2.2

60.1

733

3250

N01

ICPC

Headache

2.7

59.8

443

1515

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

2.4

59.7

583

2323

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

70.7

59.7

85000

ICD-8 Finland

Concussion, Current or unspecified

+∞

59.7

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

78.3

59.6

R01AD08

ATC

fluticasone; nasal

1.8

59.6

1228

6660

G54.0

ICD-10 Finland

Brachial plexus disorders

16.8

59.5

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

8.3

59.4

139

152

N80.0

ICD-10 Finland

Endometriosis of uterus

48.0

59.4

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

3.3

59.2

321

891

WX290

NOMESCO Finland

Other blockade of nerve

1.7

59.0

2099

13416

N03AX11

ATC

topiramate; oral

12.0

59.0

113

A03FA02

ATC

cisapride; oral, rectal

3.9

59.0

262

618

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

4.4

58.9

229

477

SPAT1325

SPAT

Vaccination

1.9

58.9

1081

5632

C10AA07

ATC

rosuvastatin; oral

2.2

58.9

690

3001

A10AD01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

99.9

58.7

Z00.0

ICD-10 Finland

General medical examination

2.2

58.7

694

3033

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.6

58.6

2661

18148

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

22.6

58.4

R03BA05

ATC

fluticasone; inhalant

2.1

58.4

739

3324

M67.4

ICD-10 Finland

Ganglion

4.7

58.4

211

408

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.9

58.3

386

1231

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

5.1

58.3

197

354

N06AB06

ATC

sertraline; oral

2.6

58.2

473

1708

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

5.4

58.2

187

317

R03BA01

ATC

beclometasone; inhalant

2.4

57.9

530

2042

M23.8

ICD-10 Finland

Other internal derangements of knee

10.9

57.8

116

R55

ICD-10 Finland

Syncope and collapse

3.3

57.8

319

897

160

Kela drug reimbursment

exenatide

+∞

57.7

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

9.0

57.7

128

A01AB09

ATC

miconazole; local oral

3.1

57.6

338

993

A02BDXX

ATC

6.0

57.5

169

257

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

13.3

57.5

105

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

4.5

57.3

219

448

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

525.5

57.0

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

525.5

57.0

SAA02

NOMESCO Finland

Basic examination of mouth

1.6

56.7

3003

21234

XF404

NOMESCO Finland

Ambulatory ECG

3.3

56.7

311

870

H3601, E103

ICD-10 Finland

+∞

56.7

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

3.8

56.5

256

614

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

4.6

56.5

208

410

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

48.9

56.4

NH3EA

NOMESCO Finland

Feet X-ray examination with load

48.9

56.4

D07AB02

ATC

hydrocortisone butyrate; topical

1.8

56.3

1135

6093

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.9

56.2

1032

5364

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

27.6

56.2

UDH02

NOMESCO Finland

Rhinopharyngoscopy

3.5

56.2

284

746

K50.9

ICD-10 Finland

Crohn disease, unspecified

7.0

56.2

146

188

C07AG02

ATC

carvedilol; oral

5.4

56.1

180

305

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

4.1

56.1

236

530

G51.0

ICD-10 Finland

Bell palsy

60.7

56.0

A02BD02

ATC

lansoprazole, tetracycline and metronidazole; systemic

7.9

56.0

135

155

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

83.0

55.8

NGF00

NOMESCO Finland

Excision of plica of synovy of knee

45.4

55.7

H3600, E103

ICD-10 Finland

+∞

55.7

TQW11

NOMESCO Finland

Vacuum treatment of wound

9.9

55.7

117

106

R01BA52

ATC

pseudoephedrine, combinations; oral

1.8

55.3

1280

7179

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

178.6

55.2

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

4.2

55.2

227

499

WX204

NOMESCO Finland

Axillary plexus blockaced

7.0

55.0

143

184

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

21.5

55.0

TK820

NOMESCO Finland

Peritoneal dialysis

93.8

54.9

M02.9

ICD-10 Finland

Reactive arthropathy, unspecified

32.0

54.7

WX100

NOMESCO Finland

Conjunctival surface anesthesia

3.8

54.6

252

614

M35.7

ICD-10 Finland

Hypermobility syndrome

39.7

54.3

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

8.8

54.2

122

125

R74

ICPC

Upper respiratory infection acute

1.8

54.2

1285

7257

R03AC03

ATC

terbutaline; inhalant

2.3

54.2

564

2316

L89

ICD-10 Finland

Decubitus ulcer and pressure area

27.6

54.1

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

58.9

54.1

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

498.3

54.0

R06.5

ICD-10 Finland

Mouth breathing

3.3

54.0

293

813

E000001

ATC

1.9

54.0

874

4333

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

71.6

54.0

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

16.0

53.8

C03AA03

ATC

hydrochlorothiazide; oral

4.1

53.8

223

494

ND1AA

NOMESCO Finland

Wrist X-ray examination

3.8

53.8

244

586

N02AC04

ATC

dextropropoxyphene; oral

10.1

53.7

112

100

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

+∞

53.7

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

4.8

53.7

192

367

M50.3

ICD-10 Finland

Other cervical disc degeneration

39.1

53.4

N39.4

ICD-10 Finland

Other specified urinary incontinence

4.1

53.3

220

485

L03AA02

ATC

filgrastim; parenteral

4.5

53.3

200

402

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

2.7

53.2

399

1374

M53.0

ICD-10 Finland

Cervicocranial syndrome

3.1

53.1

320

957

C10AA03

ATC

pravastatin; oral

5.0

53.0

182

333

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

24.1

52.9

9211

FHL

Exploration or removal of diskusprolapse

+∞

52.7

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

+∞

52.7

ABC26

NOMESCO Finland

Open discectomy of lumbar spine

+∞

52.7

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

7.5

52.5

130

156

EBA15

NOMESCO Finland

Extraction of large number of teeth

4.5

52.2

196

394

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.8

52.1

1124

6146

J46

ICD-10 Finland

Status asthmaticus

8.3

52.1

121

131

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

3.7

52.0

247

617

H03BB01

ATC

carbimazole; oral

19.3

51.9

N17.8

ICD-10 Finland

Other acute renal failure

17.9

51.8

S29

ICPC

Skin symptom/complaint other

2.2

51.7

564

2364

TQW40

NOMESCO Finland

Remowal of suture of skin

3.2

51.7

293

839

K29.7

ICD-10 Finland

Gastritis, unspecified

6.1

51.7

148

218

H36.00

ICD-10 Finland

Diabetic background retinopathy

246.4

51.6

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

9.8

51.6

109

100

A99

ICPC

Disease/condition unspecnature/site

3.3

51.6

280

777

J31.0

ICD-10 Finland

Chronic rhinitis

3.0

51.5

326

1009

N06AA10

ATC

nortriptyline; systemic

11.5

51.4

100

A29

ICPC

General symptom/complaint other

2.8

51.3

372

1252

P06

ICPC

Sleep disturbance

2.9

51.3

337

1068

J01CA08

ATC

pivmecillinam; oral

1.7

51.1

1515

9105

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

4.3

51.1

204

436

L04AB01

ATC

etanercept; parenteral

103.6

51.1

G72.8

ICD-10 Finland

Other specified myopathies

471.2

51.0

C08CA05

ATC

nifedipine; systemic

4.5

50.9

190

380

M20.2

ICD-10 Finland

Hallux rigidus

31.3

50.9

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

47.6

50.7

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

3.8

50.7

232

561

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

12.1

50.6

E66.9

ICD-10 Finland

Obesity, unspecified

6.4

50.3

139

195

RS221

NOMESCO Finland

11.4

50.2

NH1CG

NOMESCO Finland

Ankle and foot extensive MRI examination with high intensity magnet

35.2

50.0

SPAT1240

SPAT

Therapeutic discussion

2.4

49.8

474

1858

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

46.9

49.8

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

2.6

49.8

387

1359

NGF35

NOMESCO Finland

Plastic operation of joint cartilage of knee

16.5

49.8

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

+∞

49.7

A70

ICPC

Tuberculosis

+∞

49.7

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

+∞

49.7

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.8

49.7

1115

6162

JAH00

NOMESCO Finland

Laparotomy

5.6

49.7

153

247

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

7.7

49.6

121

142

A07EA02

ATC

hydrocortisone; rectal

5.0

49.5

170

311

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

9.1

49.5

109

108

Z94.4

ICD-10 Finland

Liver transplant status

33.3

49.4

3AC01

NOMESCO Finland

12.1

49.4

SAA04

NOMESCO Finland

Special inverstigation of mouth

3.3

49.3

263

720

R60.9

ICD-10 Finland

Oedema, unspecified

5.3

49.3

160

275

JFA56

NOMESCO Finland

Faecal microbiota transplantation

453.1

49.0

E87.5

ICD-10 Finland

Hyperkalaemia

22.1

48.9

G81.9

ICD-10 Finland

Hemiplegia, unspecified

+∞

48.7

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

+∞

48.7

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

232.3

48.6

EP1AE

NOMESCO Finland

Neck ultrasound examination

3.6

48.6

236

600

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

6.1

48.6

140

208

R33

ICD-10 Finland

Retention of urine

3.8

48.6

217

514

T82

ICPC

Obesity

6.1

48.5

139

205

B01AB04

ATC

dalteparin; parenteral

4.5

48.5

184

374

L16

ICPC

Ankle symptom/complaint

2.8

48.5

345

1149

NB1CG

NOMESCO Finland

Shoulder and humerus extensive MRI examination with high intensity magnet

12.9

48.2

W00

ICD-10 Finland

Fall on same level involving ice and snow

2.6

48.2

390

1400

N06AX03

ATC

mianserin; oral

4.5

48.1

181

365

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

8.9

48.1

107

108

M46.9

ICD-10 Finland

Inflammatory spondylopathy, unspecified

444.1

48.1

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

2.9

48.0

326

1053

TK810

NOMESCO Finland

Hemofiltration

27.6

47.9

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

7.7

47.8

116

135

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

6.1

47.7

137

203

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

5.1

47.6

160

286

L02

ICPC

Back symptom/complaint

3.0

47.6

304

946

J01CF05

ATC

flucloxacillin; systemic

4.4

47.4

184

383

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

22.7

47.4

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

3.2

47.3

267

762

N06AA12

ATC

doxepin; systemic

4.4

47.2

180

368

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.8

47.0

901

4718

B03BA03

ATC

hydroxocobalamin; parenteral

4.9

47.0

162

298

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

5.1

47.0

157

279

1220

FHL

Arthroscopy

8.1

46.9

111

124

SPAT1231

SPAT

Assessment of adjustments needed in living environment

36.9

46.8

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

4.6

46.8

173

343

Z96.1

ICD-10 Finland

Presence of intraocular lens

3.5

46.7

236

619

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

14.0

46.7

M01AB01

ATC

indometacin; systemic, rectal

4.0

46.6

197

444

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

16.2

46.5

R01AD12

ATC

fluticasone furoate; nasal

1.7

46.5

1295

7610

RS220

NOMESCO Finland

8.7

46.4

105

109

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

3.8

46.4

213

517

A04.0

ICD-10 Finland

Enteropathogenic Escherichia coli infection

115.9

46.3

M81.9

ICD-10 Finland

Osteoporosis, unspecified

9.9

46.2

M02AA10

ATC

ketoprofen; topical

2.2

46.2

500

2085

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

34.6

46.2

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.6

46.1

1724

10952

R1250

NOMESCO Finland

Evaluation of functional capability

11.4

46.1

JAH01

NOMESCO Finland

Laparoscopy

3.9

46.0

202

471

Z01.9

ICD-10 Finland

Special examination, unspecified

3.8

46.0

208

498

H05BX01

ATC

cinacalcet; oral

47.1

45.9

U02

ICPC

Urinary frequency/urgency

2.4

45.8

422

1625

L29

ICPC

Musculoskeletal sympt/complt other

3.5

45.8

226

582

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.5

45.8

393

1457

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

+∞

45.7

G04BD12

ATC

mirabegron; oral

3.4

45.7

242

659

A02BA04

ATC

nizatidine; systemic

3.4

45.7

242

659

ZY010

NOMESCO Finland

Hospital outpatient

3.4

45.6

235

626

M54

ICD-10 Finland

Dorsalgia

2.5

45.6

404

1524

NDM20

NOMESCO Finland

Excision of synovial ganglion of wrist or hand

55.5

45.6

SPAT1215

SPAT

Assessment of need for medical rehabilitation

5.3

45.6

147

251

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.9

45.5

793

4011

E05.0

ICD-10 Finland

Thyrotoxicosis with diffuse goitre

148.5

45.5

XQ800

NOMESCO Finland

Prick test

2.6

45.5

349

1216

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

9.2

45.3

-1

NOMESCO Finland

1.6

45.2

1482

9093

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.6

45.1

1839

11919

Z01.2

ICD-10 Finland

Dental examination

1.6

45.1

1801

11612

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

417.0

45.1

TND11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in joint, wrist or hand

417.0

45.1

K50.8

ICD-10 Finland

Other Crohn disease

5.4

45.1

142

236

E87.6

ICD-10 Finland

Hypokalaemia

6.2

45.0

128

187

J96.1

ICD-10 Finland

Chronic respiratory failure

18.4

44.9

J01DA06

ATC

[U] cefuroxime; systemic

2.1

44.9

604

2766

Z02.7

ICD-10 Finland

Issue of medical certificate

3.4

44.9

235

634

J01MA06

ATC

norfloxacin; oral

2.2

44.8

519

2228

UDQ12

NOMESCO Finland

Flexible laryngoscopy

3.7

44.8

209

514

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

37.6

44.7

TNG10

NOMESCO Finland

Puncture of knee

+∞

44.7

00820

ICD-8 Finland

Enteritis due to other specified organism, Other specified bacteria

+∞

44.7

72410

ICD-8 Finland

Internal derangement of joint, Other shoulder derangement

+∞

44.7

N80.9

ICD-10 Finland

Endometriosis, unspecified

54.5

44.7

SPAT1212

SPAT

Extensive examination of musculoskeletal system

3.2

44.5

251

715

M51.9

ICD-10 Finland

Intervertebral disc disorder, unspecified

60.1

44.5

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

2.9

44.5

290

913

K90

ICPC

Stroke/cerebrovascular accident

145.5

44.5

K59.0

ICD-10 Finland

Constipation

4.2

44.4

181

395

I20.09

ICD-10 Finland

Unstable angina

5.4

44.3

141

237

R35

ICD-10 Finland

Polyuria

3.8

44.2

200

479

WX111

NOMESCO Finland

Local infiltration anesthesia

408.0

44.1

NB1BG

NOMESCO Finland

Shoulder and humerus MRI examination with high intensity magnet

11.9

44.1

K51.1

ICD-10 Finland

Ulcerative (chronic) ileocolitis

7.6

44.0

108

128

SPAT1252

SPAT

Overall medication plan or its review

4.1

44.0

180

394

N05AA02

ATC

levomepromazine; systemic

4.0

44.0

187

424

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

+∞

43.7

A10BB01

ATC

glibenclamide; oral

+∞

43.7

183

Kela drug reimbursment

Lamotrigin and topiramate

+∞

43.7

-50

ICPC

Medication/prescr/renewal

5.1

43.7

146

260

R10.0

ICD-10 Finland

Acute abdomen

4.7

43.6

156

299

K29.6

ICD-10 Finland

Other gastritis

11.8

43.3

XKD00

NOMESCO Finland

Uroflowmetry

2.3

43.3

422

1672

K50.1

ICD-10 Finland

Crohn disease of large intestine

6.4

43.2

120

170

NGB40

NOMESCO Finland

Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis

399.0

43.1

ACC53

NOMESCO Finland

Release of ulnar nerve

399.0

43.1

A06AC51

ATC

ispaghula, combinations; systemic

3.8

43.0

193

459

M65.3

ICD-10 Finland

Trigger finger

6.7

42.9

114

152

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

3.2

42.9

245

705

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

16.1

42.9

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

7.4

42.7

106

128

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

139.5

42.6

R52.0

ICD-10 Finland

Acute pain

4.7

42.5

153

295

D07AC13

ATC

mometasone; topical

1.7

42.5

1127

6502

SPAT1312

SPAT

General health counselling

1.7

42.5

1178

6881

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

2.4

42.5

405

1584

NBA30

NOMESCO Finland

Exploration of joint of shoulder or upper arm, arthroscopic

16.3

42.5

M09AX01

ATC

hyaluronic acid; parenteral

10.3

42.4

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

4.3

42.3

165

345

C10AA04

ATC

fluvastatin; oral

4.4

42.3

162

333

R05FA02

ATC

opium derivatives and expectorants; systemic

1.6

42.2

1537

9645

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

4.9

42.2

146

270

M01CB01

ATC

sodium aurothiomalate; parenteral

390.0

42.1

NHG77

NOMESCO Finland

Arthroplasty of interphalangeal tarsal joint(s)

390.0

42.1

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.5

42.1

362

1342

M21.4

ICD-10 Finland

Flat foot [pes planus] (acquired)

8.3

41.9

105

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

7.3

41.8

105

129

G45.0

ICD-10 Finland

Vertebro-basilar artery syndrome

200.3

41.8

H36.01

ICD-10 Finland

Diabetic maculopathy

200.3

41.8

A16.0

ICD-10 Finland

Tuberculosis of lung, bacteriologically and histologically negative

+∞

41.7

A10BG03

ATC

pioglitazone; oral

+∞

41.7

ZZA00

NOMESCO Finland

Split skin graft

6.0

41.6

120

179

H53.1

ICD-10 Finland

Subjective visual disturbances

3.5

41.5

206

533

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

4.0

41.5

177

403

XA402

NOMESCO Finland

ENMG

14.2

41.4

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

4.7

41.3

148

284

N06AX12

ATC

bupropion; oral

3.0

41.3

259

796

T78.4

ICD-10 Finland

Allergy, unspecified

3.4

41.3

212

564

H53.2

ICD-10 Finland

Diplopia

6.9

41.1

107

139

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

7.2

41.0

104

130

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

24.3

41.0

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

50.5

40.9

M03BX01

ATC

baclofen; systemic

17.9

40.9

7177A

ICD-9 Finland

Internal derangement of knee, Chondromalacia of patella

+∞

40.8

7170A

ICD-9 Finland

Internal derangement of knee, Old bucket handle tear of medial meniscus

+∞

40.8

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

5.3

40.6

131

224

V03AE03

ATC

lanthanum carbonate; oral

83.8

40.5

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

4.1

40.5

165

360

R04.0

ICD-10 Finland

Epistaxis

3.5

40.5

199

511

Z2445

NOMESCO Finland

Psychologist

4.0

40.5

172

390

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

6.1

40.4

116

172

L11

ICPC

Wrist symptom/complaint

2.9

40.4

270

863

A02BC04

ATC

rabeprazole; oral

2.6

40.4

320

1132

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

5.4

40.2

127

212

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

2.3

40.2

388

1527

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

3.1

40.2

242

723

A04.3

ICD-10 Finland

Enterohaemorrhagic Escherichia coli infection

372.0

40.2

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

3.6

40.1

193

487

N06AB05

ATC

paroxetine; oral

2.9

40.1

266

847

N30.9

ICD-10 Finland

Cystitis, unspecified

3.5

40.1

197

506

L89

ICPC

Osteoarthrosis of hip

17.6

40.0

M01AX01

ATC

nabumetone; oral

5.5

40.0

125

206

SPAT1202

SPAT

Intra-articular injection

10.5

40.0

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

4.5

39.9

148

295

L03.0

ICD-10 Finland

Cellulitis of finger and toe

3.0

39.8

250

769

M03.2*A04.6

ICD-10 Finland

Postinfectious arthropathy in enteritis due to Yersinia enterocolitica

+∞

39.8

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

+∞

39.8

WX702

NOMESCO Finland

Supraglottic ventilation device

3.2

39.7

224

638

NG2AA

NOMESCO Finland

Patella X-ray examination

18.8

39.7

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

8.1

39.6

103

B18.2

ICD-10 Finland

Chronic viral hepatitis C

82.0

39.6

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

4.8

39.4

139

263

A12BA01

ATC

potassium chloride; oral

9.1

39.2

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

3.4

39.2

204

548

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

362.9

39.2

NG4AA

NOMESCO Finland

Lower leg X-ray examination

5.2

39.1

127

219

NG1DA

NOMESCO Finland

X-ray of knees

48.5

39.1

NBG10

NOMESCO Finland

Acromioplastia

35.6

39.1

K07.60

ICD-10 Finland

Snapping jaw

3.4

39.1

203

545

WX725

NOMESCO Finland

Noninvasive ventilation

3.6

39.0

185

462

M00.9

ICD-10 Finland

Pyogenic arthritis, unspecified

186.9

38.9

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

3.9

38.8

167

383

SPAT1053

SPAT

Memory test

4.1

38.8

160

353

B02.9

ICD-10 Finland

Zoster without complication

3.6

38.8

189

482

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

4.5

38.8

144

287

0084E

ICD-9 Finland

Intestinal infections due to other organisms, Other specified bacteria[ENTERITIS CAMPYLOBACTER]

+∞

38.8

K77.0*B25.1

ICD-10 Finland

Cytomegaloviral hepatitis

+∞

38.8

NDG60

NOMESCO Finland

Arthroplasty of first CMC joint

+∞

38.8

72510

ICD-8 Finland

Displacement of intervertebral disk, Lumbalis cum prolapsu disci

+∞

38.8

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

3.6

38.8

183

455

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

11.8

38.7

R51

ICD-10 Finland

Headache

3.4

38.7

197

520

N18

ICPC

Paralysis/weakness

68.4

38.7

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.7

38.7

1001

5713

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

3.6

38.7

187

474

WX200

NOMESCO Finland

Interscalenous plexus blockade

13.3

38.7

A08

ICPC

Swelling

5.4

38.7

121

200

C02EA02

ATC

8.7

38.7

M01AG02

ATC

tolfenamic acid; oral, rectal

1.9

38.6

615

2996

A03CA02

ATC

clidinium and psycholeptics; oral

3.8

38.6

175

420

R21

ICPC

Throat symptom/complaint

1.8

38.6

836

4521

M43.0

ICD-10 Finland

Spondylolysis

40.5

38.6

R03AC12

ATC

salmeterol; inhalant

4.2

38.6

154

330

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

2.9

38.5

258

825

ZYC01

NOMESCO Finland

Remote contact by phone

3.5

38.3

190

492

H26.3

ICD-10 Finland

Drug-induced cataract

25.8

38.2

NHK40

NOMESCO Finland

Osteotomy or rotation osteotomy of II-V metatarsal or tarsal bone

353.9

38.2

ZXE40

NOMESCO Finland

More than seven and less than nine hours

5.0

38.2

128

229

N05BA06

ATC

lorazepam; systemic, sublingual

3.3

38.2

202

550

J01FA15

ATC

telithromycin; oral

2.2

38.1

423

1777

H57.1

ICD-10 Finland

Ocular pain

4.6

38.0

138

269

C09BA02

ATC

enalapril and diuretics; systemic

3.5

37.9

189

491

M17.3

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3000494) Fungus identified in Specimen by Culture

1547

3892

3.28

322.40

2.1

1.3

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

493

448

8.41

317.68

2.9

1.6

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

610

720

6.54

317.18

1.9

1.3

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1049

2048

4.08

315.02

2.5

1.9

ug/l

8.5

11.2

1.73

909

1819

(3034860) Kappa light chains.free [Mass/volume] in Serum

542

566

7.35

313.15

5.4

3.7

mg/l

62.2

47.8

1.24

448

478

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

609

730

6.44

312.19

1.9

1.3

u/ml

24.8

22.6

0.11

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

538

564

7.32

309.80

5.4

3.7

mg/l

49.8

35.9

0.86

443

475

(3025159) Blasts/100 leukocytes in Blood

1045

2066

4.03

308.43

6.6

3.6

0.1

0.3

0.77

452

525

(3021788) Differential panel - Synovial fluid

264

28.25

308.08

1.7

1.1

—

(3027945) Reticulocytes/100 erythrocytes in Blood

1801

3138

4.95

307.65

4.0

2.6

1.9

1.6

16.41

1635

2808

(3037467) Urinalysis macro (dipstick) panel - Urine

6231

26103

3.29

307.65

7.3

2.9

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1211

590

17.06

307.65

1.6

1.2

—

(3023520) Reticulocytes [#/volume] in Blood

1410

2196

5.34

307.65

4.0

2.8

e9/l

70.9

67.1

2.23

1081

1603

(3021960) Folate [Moles/volume] in Serum or Plasma

2517

6446

3.54

307.65

1.8

1.4

nmol/l

19.7

20.3

1.08

2243

5500

(3027273) Bicarbonate [Moles/volume] in Venous blood

741

1043

5.54

307.65

7.4

2.7

mmol/l

24.7

25.3

3.60

716

1013

(3002030) Lymphocytes/100 leukocytes in Blood

5256

17411

3.80

307.65

12.2

4.5

26.4

28.9

40.26

4995

16161

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

638

609

8.12

307.65

2.8

1.5

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2972

7524

3.77

307.65

4.1

2.5

ng/l

2398.6

1097.1

18.10

2627

6451

(3019198) Lymphocytes [#/volume] in Blood

5495

17924

4.06

307.65

11.4

4.5

e9/l

1.8

2.0

2.88

5025

15430

(3021601) Nitrite [Presence] in Urine by Test strip

4374

18054

2.46

307.65

7.5

3.4

estimate

0.0

1.60

864

3127

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

919

1513

4.80

307.65

2.1

1.5

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1292

2519

4.18

307.65

11.8

7.9

g/l

116.1

121.0

11.04

1253

2429

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1813

2775

5.68

307.65

2.4

1.5

—

(3010375) cycloSPORINE [Mass/volume] in Blood

307

24.06

307.65

34.2

29.5

ug/l

118.5

136.6

1.59

259

(3013115) Eosinophils [#/volume] in Blood

5554

17928

4.17

307.65

12.0

4.8

e9/l

0.2

2.23

5072

15365

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1264

2203

4.69

307.65

2.6

2.8

nmol/l

354.1

394.6

6.24

1176

2057

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

5176

15770

4.18

307.65

16.4

5.2

mmol/l

1.2

4.49

4517

13209

(3014576) Chloride [Moles/volume] in Serum or Plasma

1694

3768

3.79

307.65

12.0

6.9

mmol/l

104.1

104.9

6.42

1659

3720

(3015377) Calcium [Moles/volume] in Serum or Plasma

3352

11741

2.70

307.65

5.0

4.1

mmol/l

2.3

2.4

17.74

2960

10472

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3571

12466

2.78

307.65

5.6

3.1

u/l

33.5

34.8

0.33

3422

11932

(3026008) Bacteria identified in Urine by Culture

3289

8900

3.63

307.65

4.5

2.3

—

(3017181) Myelocytes/100 leukocytes in Blood

1270

2297

4.51

307.65

6.6

3.6

0.9

0.11

574

656

(3024354) Oxygen [Partial pressure] in Venous blood

1233

1901

5.30

307.65

6.9

2.8

kpa

4.9

4.6

2.61

1182

1838

(3012516) Albumin [Mass/volume] in Urine

2526

5479

4.25

307.65

4.6

1.8

mg/l

969.2

518.9

2.30

1780

2826

(3019060) Gas panel - Arterial blood

982

1419

5.52

307.65

6.7

4.6

—

(3004588) Protein electrophoresis panel - Serum or Plasma

1014

1203

6.78

307.65

3.7

2.4

—

(3028026) IgM [Mass/volume] in Serum or Plasma

1155

1537

6.12

307.65

2.1

1.9

g/l

1.2

1.4

1.54

1050

1394

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

3832

11191

3.56

307.65

5.1

2.4

ng/l

60.3

65.3

0.10

2832

6431

(3018010) Neutrophils/100 leukocytes in Blood

5185

17069

3.78

307.65

11.6

4.4

58.5

56.3

26.07

4934

15941

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

699

453

12.08

307.65

4.6

2.8

u/ml

1495.2

945.5

0.24

(3022096) Basophils/100 leukocytes in Blood

5050

15923

3.90

307.65

12.0

4.6

0.6

0.7

6.10

4801

14775

(3009343) pH of Capillary blood

1101

1188

7.53

307.65

6.5

3.8

7.4

1.25

135

153

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1601

3751

3.55

307.65

1.4

1.1

iu/ml

27.2

23.7

0.20

529

1111

(3006315) Basophils [#/volume] in Blood

5443

17200

4.19

307.65

11.3

4.5

e9/l

0.0

0.35

4924

14479

(3032080) INR in Blood by Coagulation assay

4394

12228

4.10

307.65

13.2

6.6

inr

1.2

0.03

1164

3563

(3009508) Creatinine [Moles/volume] in Urine

2708

6633

3.80

307.65

4.5

1.8

mmol/l

6.9

8.3

33.93

2349

5698

(3021440) Promyelocytes/100 leukocytes in Blood

1136

2179

4.19

307.65

6.7

3.6

0.1

0.45

537

607

(3020779) Urea [Moles/volume] in Serum or Plasma

1705

2446

6.00

307.65

17.2

5.7

mmol/l

11.4

8.3

42.51

1649

2359

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2169

3778

5.16

307.65

4.5

1.9

21.6

24.3

10.65

1871

3284

(3016502) Oxygen saturation in Arterial blood

1449

2614

4.61

307.65

10.8

7.8

95.1

96.3

7.20

1384

2524

(3033658) Prothrombin time (PT) actual/Normal

2894

9393

2.81

307.65

7.9

3.5

90.2

91.4

1.56

2824

9208

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1114

1200

7.56

307.65

6.5

3.8

kpa

5.1

0.05

1046

1112

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1236

1647

6.16

307.65

7.2

3.2

ng/l

124.2

79.9

23.67

1120

1434

(3009261) Glucose [Presence] in Urine by Test strip

4433

18253

2.48

307.65

5.5

2.5

estimate

0.0

0.00

843

3125

(3027801) Oxygen [Partial pressure] in Arterial blood

1599

2957

4.56

307.65

10.3

7.3

kpa

11.7

13.7

28.44

1517

2828

(3019069) Monocytes/100 leukocytes in Blood

5194

16638

3.92

307.65

12.6

4.8

8.7

8.6

1.80

4948

15520

(3001122) Ferritin [Mass/volume] in Serum or Plasma

4388

16666

2.75

307.65

4.6

2.3

ug/l

185.0

118.6

17.87

4124

15652

(3005719) IgG [Mass/volume] in Serum or Plasma

1421

1851

6.43

307.65

4.0

2.6

g/l

9.9

10.8

6.88

1327

1695

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2201

5920

3.24

307.65

5.2

2.8

ng/l

432.7

958.0

5.46

1741

4432

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1410

3312

3.48

307.65

3.3

2.3

g/l

0.2

1.60

1305

3138

(3020682) Albumin/Creatinine [Ratio] in Urine

2630

5828

4.20

307.65

5.3

2.0

mg/mmol

19.9

7.5

12.45

1822

3043

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

487

423

8.80

307.65

2.0

1.3

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2257

4107

4.98

307.65

4.4

1.9

g/l

2.2

2.4

20.04

2135

3803

(3037522) Nuclear Ab [Titer] in Serum

1653

3019

4.64

307.65

1.5

1.2

titre

514.9

476.8

0.30

378

476

(3020630) Protein [Mass/volume] in Serum or Plasma

1226

1783

5.62

307.65

4.0

2.9

g/l

64.3

66.0

8.15

1123

1647

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2661

1777

14.94

307.65

2.9

1.5

—

(3001604) Monocytes [#/volume] in Blood

5422

17140

4.17

307.65

11.3

4.5

e9/l

0.6

9.13

4894

14434

(3023368) Bacteria identified in Blood by Culture

4135

7819

6.18

307.65

8.0

3.7

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

4160

14008

3.12

307.65

3.2

1.9

nmol/l

75.7

76.4

0.84

3821

12734

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2556

4231

5.71

307.65

2.8

1.6

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1809

2778

5.66

307.65

2.5

1.5

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

7027

30043

3.98

307.65

16.2

6.5

u/l

82.6

80.0

3.08

6763

28047

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

664

629

8.21

307.65

2.7

1.5

—

(3018095) Leukocytes [#/volume] in Urine

3708

12353

2.99

307.65

6.6

2.8

e6/l

73.5

107.6

2.03

2911

8060

(3025941) Bacteria identified in Stool by Culture

1359

1847

6.11

307.65

1.6

1.2

—

(3013707) Erythrocyte sedimentation rate by Westergren method

6513

26590

3.68

307.65

6.6

2.3

mm/h

16.5

10.4

124.32

6160

24093

(3014111) Lactate [Moles/volume] in Serum or Plasma

1357

2529

4.41

307.65

10.4

6.9

mmol/l

1.4

1.3

2.90

1307

2432

(3026493) Urate [Moles/volume] in Serum or Plasma

2974

7691

3.68

307.65

4.7

2.1

umol/l

2550.1

6256.0

5.44

2652

6846

(3013826) Glucose [Moles/volume] in Serum or Plasma

5718

19472

4.01

307.65

9.7

3.6

mmol/l

6.8

6.2

76.89

5485

17837

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1075

1143

7.62

307.65

6.5

3.8

mmol/l

1.4

1.8

1.25

810

819

(3002179) Metamyelocytes/100 leukocytes in Blood

1162

2090

4.49

307.65

6.3

3.6

0.8

0.6

1.32

415

496

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

452

283

12.18

307.65

8.3

6.6

mg/l

11.7

11.2

1.03

386

268

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

650

623

8.10

307.65

1.7

1.5

iu/ml

9.0

25.9

0.32

162

130

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

3932

10090

4.21

307.65

4.3

2.3

u/l

55.7

62.6

6.36

3711

9307

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

5785

18897

4.31

307.65

11.3

6.8

umol/l

10.7

12.3

15.34

5561

17984

(3042936) Bacteria identified in Isolate by Culture

2211

3842

5.20

307.65

3.1

1.6

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

364

175

15.73

307.65

1.6

1.1

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

639

655

7.56

307.65

3.1

2.1

ug/l

441.3

406.6

0.15

594

625

(3022948) Iron [Moles/volume] in Serum or Plasma

2391

4498

4.88

307.65

4.3

1.9

umol/l

11.7

14.1

38.67

2269

4185

(3022217) INR in Platelet poor plasma by Coagulation assay

1473

3413

3.55

307.65

24.6

18.9

inr

1.4

0.32

215

456

(3030467) Casts [#/volume] in Urine by Automated count

3060

9279

3.10

307.65

5.6

2.5

e6/l

0.4

0.5

2.36

2500

6424

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

861

848

8.06

307.65

4.3

2.4

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

4468

17799

2.61

307.65

6.5

3.4

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

3215

6639

4.88

307.65

2.9

1.6

u/l

203.2

204.1

0.02

3043

6208

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

3169

7277

4.31

307.65

3.0

1.9

mg/l

3.1

2.9

4.47

2792

6113

(3048689) Calprotectin [Mass/mass] in Stool

1794

4307

3.53

307.65

3.9

2.6

ug/g

256.6

135.2

13.57

1527

3433

(42870588) Differential panel, method unspecified - Blood

4225

10754

4.44

307.65

11.5

5.0

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2042

5613

3.12

307.65

4.2

2.3

e6/l

1.1

1.4

0.83

1288

2830

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1972

3699

4.67

307.65

6.7

4.9

u/l

252.0

250.7

0.08

1871

3546

(3031040) Bacteria [#/volume] in Urine by Automated count

6075

25066

3.25

307.65

7.1

3.0

e6/l

1159.3

626.9

0.37

102

337

(3009445) Proteinase 3 Ab [Units/volume] in Serum

743

870

6.68

307.65

1.7

1.2

u/ml

11.7

9.0

0.17

(3007853) Bacteria identified in Skin by Aerobe culture

1730

3281

4.50

307.65

2.4

1.5

—

(3002032) Base excess in Venous blood by calculation

1589

2338

5.77

307.65

8.5

3.1

mmol/l

1.5

1.8

1.99

1310

1914

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2030

4029

4.43

307.65

3.5

2.2

30.1

30.2

0.23

1969

3930

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3938

11768

3.51

307.65

2.4

1.6

pmol/l

95.2

96.1

0.51

2325

5971

(3022313) Gas panel - Capillary blood

797

829

7.57

307.65

6.8

4.1

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1960

5538

3.00

307.65

4.6

2.4

e6/l

2.6

2.4

0.41

1212

2773

(3008152) Bicarbonate [Moles/volume] in Arterial blood

862

1392

4.87

307.65

10.8

6.2

mmol/l

24.4

24.6

0.64

813

1292

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2500

6424

3.52

307.65

2.5

1.6

mg/l

1.4

0.03

1992

4845

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1514

3309

3.79

307.65

1.3

1.1

u/ml

11.7

2.2

6.43

525

1351

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

895

926

7.69

307.65

2.8

1.8

ug/l

2.3

2.4

0.08

815

830

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2703

8830

2.74

307.65

4.0

2.1

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1655

4215

3.27

307.65

5.4

2.9

umol/l

8.0

10.1

2.68

1449

3737

(3019309) Folate [Moles/volume] in Red Blood Cells

2187

4378

4.46

307.65

2.0

1.6

nmol/l

1140.3

1144.9

0.07

1743

3188

(3002582) Erythrocytes [#/volume] in Urine

3324

10347

3.10

307.65

5.8

2.5

e6/l

41.8

120.2

3.87

2776

7410

(3004119) Hemoglobin [Mass/volume] in Venous blood

920

1462

4.98

307.65

7.5

2.9

g/l

119.8

130.4

25.01

894

1435

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2461

4957

4.57

307.65

7.1

3.8

mmol/l

0.8

22.14

2330

4686

(3000991) Gas panel - Venous blood

1379

2500

4.55

307.65

13.4

7.7

—

(3026782) Osmolality of Urine

2384

6129

3.47

307.65

4.8

2.2

mosm/kgh2o

521.0

564.5

16.50

2131

5135

(3003458) Phosphate [Moles/volume] in Serum or Plasma

2202

3460

5.78

307.65

14.7

4.9

mmol/l

1.1

1.0

11.25

2098

3252

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

692

715

7.54

307.65

7.3

4.3

mmol/l

24.6

24.7

0.31

651

662

(3012544) pH of Venous blood

1644

2444

5.75

307.65

8.3

3.2

7.4

—

(3000475) Leukocytes [#/volume] in Synovial fluid

339

118

21.69

307.65

1.9

1.2

e6/l

11682.0

22430.6

0.58

260

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

946

601

12.66

307.65

12.9

4.4

iu/ml

3757.0

671.4

0.88

318

(3024561) Albumin [Mass/volume] in Serum or Plasma

4896

14380

4.16

307.65

10.9

4.7

g/l

34.0

35.8

70.19

4616

13370

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1599

2961

4.55

307.65

10.3

7.3

kpa

5.0

5.1

2.01

1520

2832

(3018418) pH of Serum or Plasma

3224

8967

3.49

307.65

9.6

3.4

7.4

0.08

602

1647

(3017143) Hepatitis C virus Ab [Presence] in Serum

1683

4327

3.24

307.65

2.2

1.6

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

965

1337

5.76

307.65

8.9

3.4

mmol/l

23.8

24.3

3.09

881

1251

(3026250) Tacrolimus [Mass/volume] in Blood

313

26.19

307.65

41.8

31.2

ug/l

7.4

7.5

0.42

283

(40768797) Stomach Pathology biopsy report

1781

4281

3.52

307.65

1.3

1.2

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1006

1104

7.33

307.65

2.2

1.7

g/l

1.5

1.4

1.76

891

925

(40758558) Short blood count panel - Blood

2895

9476

2.79

307.65

12.6

7.0

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1581

2346

5.72

307.65

8.5

3.1

kpa

5.8

0.00

1526

2279

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1001

1540

5.19

307.65

1.8

1.4

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

697

844

6.43

307.65

4.6

3.2

u/ml

0.3

3.02

402

435

(3003396) Base excess in Arterial blood by calculation

1608

2962

4.58

307.65

10.3

7.3

mmol/l

1.0

0.8

0.69

1305

2379

(3044640) Blood type and Crossmatch panel - Blood

3455

11592

2.87

307.65

4.4

2.1

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

4822

14187

4.10

307.65

13.5

4.9

mmol/l

1.2

4.99

4487

12757

(3035350) Ketones [Presence] in Urine by Test strip

4380

17801

2.51

307.65

5.5

2.4

estimate

0.0

1.34

833

3018

(36304419) Bacteria [Presence] in Urine

2974

9159

3.02

307.65

5.4

2.4

—

(3007164) IgA [Mass/volume] in Serum or Plasma

2308

6637

3.05

307.65

1.8

1.4

g/l

2.4

2.3

0.97

1530

4142

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1993

5707

2.97

307.65

1.8

1.4

pmol/l

16152462.6

23833773.9

0.34

1684

4800

(3013650) Neutrophils [#/volume] in Blood by Automated count

5911

21454

3.82

307.65

17.6

8.7

e9/l

4.4

3.9

25.59

5386

18278

(3006504) Eosinophils/100 leukocytes in Blood

5153

16537

3.89

307.65

12.1

4.6

2.6

2.9

15.17

4895

15317

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

708

538

10.30

307.65

2.0

1.4

—

(3000850) Epithelial cells [#/volume] in Urine

2476

6409

3.48

307.65

4.5

2.1

e6/l

5.3

5.8

0.93

2253

5468

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

604

730

6.38

307.22

4.1

2.1

g/l

7.4

7.1

2.85

423

572

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

603

730

6.37

306.23

4.1

2.1

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

525

543

7.41

305.64

5.4

3.8

ratio

2.1

4.1

0.38

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

601

729

6.35

304.65

4.1

2.1

g/l

3.7

3.8

1.01

407

532

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

418

322

9.86

302.29

2.3

1.5

—

(42529406) Shigella sp [Presence] in Stool by Culture

666

909

5.67

301.35

1.5

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

663

904

5.68

300.28

1.5

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

663

904

5.68

300.28

1.5

1.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

417

325

9.74

299.22

2.3

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

420

331

9.64

299.14

2.3

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

414

324

9.70

296.23

2.3

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

414

324

9.70

296.23

2.3

1.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

413

323

9.70

295.64

2.3

1.5

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1373

3397

3.28

292.01

4.0

2.3

u/l

44.6

48.6

0.13

1203

2958

(3021589) Normoblasts [#/volume] in Blood

4068

17401

2.26

290.52

19.0

6.9

e9/l

0.0

0.75

3403

13834

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

566

681

6.38

288.83

1.9

1.3

u/ml

117.7

108.7

0.34

112

142

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

404

318

9.63

287.90

1.9

1.3

—

(3023183) Ammonium ion [Moles/volume] in Plasma

484

490

7.54

286.51

3.6

2.6

umol/l

33.3

37.7

1.65

429

434

(3013512) EKG study

2646

9424

2.47

286.04

5.1

2.8

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

570

707

6.19

282.70

1.6

1.5

titre

434.5

164.2

0.93

(3011397) Hemoglobin [Presence] in Urine by Test strip

2265

7535

2.58

281.78

5.0

2.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

388

297

9.89

281.62

1.6

1.3

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1037

2180

3.78

280.55

3.9

2.4

ng/l

259.8

200.6

2.49

955

2002

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

558

683

6.27

280.16

3.9

2.1

g/l

9.9

10.5

1.58

452

581

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

692

1054

5.09

278.75

6.4

2.4

0.7

0.6

2.89

673

1014

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

503

552

6.96

278.35

2.0

1.2

g/l

1.1

1.2

0.73

474

520

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

7828

44705

2.85

278.20

36.8

8.2

mg/l

27.2

26.9

0.39

7030

31418

(3000570) Elastase.pancreatic [Mass/mass] in Stool

542

651

6.38

276.86

1.5

1.4

ug/g

268.8

277.1

0.31

326

387

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

577

745

5.95

275.35

1.5

1.2

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

558

700

6.12

273.69

4.1

2.1

g/l

3.1

3.0

0.93

414

559

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

491

535

7.00

273.32

2.0

1.2

g/l

0.2

1.57

460

500

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

558

706

6.06

271.45

1.5

1.3

u/ml

281.9

252.3

1.18

375

470

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

406

355

8.67

268.72

1.9

1.3

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

279

127

16.47

268.42

1.8

1.5

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

378

304

9.40

265.33

1.9

1.3

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

273

122

16.77

264.75

1.8

1.5

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

502

592

6.47

260.55

1.8

—

(40760888) Immunoglobulin light chains.free panel - Serum

422

408

7.85

258.87

5.5

3.8

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

506

619

6.24

253.87

1.7

1.2

iu/ml

16.2

4.3

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

360

294

9.24

249.95

1.6

1.2

mg/l

593.1

439.9

1.26

341

274

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

374

326

8.67

247.96

2.3

1.4

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

800

1518

4.11

247.42

11.7

9.6

mmol/l

24.0

24.3

1.18

747

1440

(3015235) Bicarbonate [Moles/volume] in Capillary blood

455

510

6.78

246.91

4.6

3.1

mmol/l

23.9

24.7

2.42

411

445

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

910

1912

3.74

245.18

11.5

7.1

mmol/l

24.6

24.8

0.78

898

1901

(3004809) Band form neutrophils/100 leukocytes in Blood

420

435

7.32

243.68

5.0

3.5

1.5

1.9

0.72

339

338

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

278

157

13.27

241.03

2.1

1.4

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

6041

31628

2.14

240.95

4.4

3.1

pmol/l

14.8

14.5

12.20

5574

28695

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

634

1018

4.80

240.10

1.8

2.2

u/l

38.8

41.0

1.50

553

928

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1133

2797

3.22

239.28

1.7

1.5

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

608

946

4.94

238.54

7.7

3.1

50.3

45.3

3.74

602

935

(3044941) Cell count panel - Synovial fluid

221

21.97

238.47

1.4

1.2

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1838

5958

2.56

236.45

3.7

3.6

mmol/l

2.5

2.4

3.12

1598

5270

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

322

244

9.92

235.00

2.9

1.9

—

(3037756) Immunofixation for Serum or Plasma

396

399

7.51

234.90

2.3

1.8

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

540

764

5.41

234.61

2.1

1.4

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2161

7601

2.40

233.37

1.4

1.2

u/ml

1.9

2.4

0.72

517

2057

(3048929) Epstein Barr virus Ab [Presence] in Serum

694

1240

4.33

231.27

1.5

1.2

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

2226

7989

2.36

229.32

2.2

1.8

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

578

895

4.95

227.82

7.2

3.7

mg/l

2.0

1.2

46.10

547

834

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

323

258

9.41

227.56

1.5

1.2

mmol/l

3.8

3.5

5.25

303

243

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

484

633

5.82

227.54

3.8

2.3

g/l

0.8

1.3

1.11

412

550

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1181

3079

3.06

227.36

5.0

2.5

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

257

145

13.25

222.86

3.1

2.1

ug/min

218.3

103.1

1.10

153

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

219

18.54

221.85

2.5

1.5

u/ml

44901.7

3287.6

1.24

(40760892) CBC W Ordered Manual Differential panel - Blood

2223

8079

2.32

221.57

8.1

3.2

—

(44806118)

336

296

8.54

220.89

2.2

1.4

—

(44790049)

336

296

8.54

220.89

2.2

1.4

—

(44790047)

336

296

8.54

220.89

2.2

1.4

—

(44790048)

336

296

8.54

220.89

2.2

1.4

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

793

1630

3.78

219.58

14.2

9.0

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

305

237

9.66

218.86

6.8

3.9

—

(40768446) Kidney Pathology biopsy report

191

26.29

218.52

2.2

1.7

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

816

1722

3.69

217.70

13.1

9.1

1.4

1.3

1.60

808

1717

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

300

230

9.79

217.19

3.0

1.9

—

(3028626) Oxygen [Partial pressure] in Capillary blood

444

562

6.00

215.32

5.6

4.0

kpa

8.4

8.6

1.15

422

530

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

224

102

16.37

215.29

1.9

1.6

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

224

102

16.37

215.29

1.9

1.6

—

(3044290) Cell count panel - Cerebral spinal fluid

304

241

9.47

215.21

1.8

1.3

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

665

1222

4.19

213.58

3.3

1.8

—

(3011412) CD3 cells [#/volume] in Blood

311

258

9.05

213.39

3.2

2.3

e9/l

1.3

1.1

1.59

171

166

(3042733) HLA Ab [Presence] in Serum

200

20.95

212.32

4.9

3.7

—

(3022145) Colonoscopy Study observation

1441

4346

2.68

212.13

1.6

1.4

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

409

483

6.41

211.57

1.9

1.3

—

(40761535) Cells panel - Urine sediment

875

1979

3.45

210.73

5.4

2.4

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

473

660

5.45

208.16

2.2

1.4

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

7850

46830

2.50

207.91

38.1

9.3

mmol/l

139.3

139.9

78.93

7725

44999

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1865

6430

2.40

207.73

2.1

1.6

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

171

31.71

206.07

2.0

1.1

63.2

63.3

0.01

135

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

308

265

8.72

205.90

1.8

1.3

e6/l

535.9

229.6

0.75

259

198

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

308

265

8.72

205.90

1.8

1.3

e6/l

11.8

9.1

0.20

245

185

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

323

303

8.01

202.48

2.4

1.4

—

(3019225) pH of Specimen

1113

2990

2.95

202.29

8.6

3.2

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

465

658

5.37

201.61

1.3

1.1

u/ml

1.0

0.6

0.45

(3023103) Potassium [Moles/volume] in Serum or Plasma

7857

47078

2.48

201.56

38.8

9.4

mmol/l

4.0

3.9

20.52

7717

45113

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

609

1092

4.28

201.50

3.9

2.3

g/l

3.5

0.35

579

1047

(1616796) Gas panel - Central venous blood

393

469

6.33

201.27

6.1

2.9

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

430

569

5.72

199.56

1.6

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

430

569

5.72

199.56

1.6

1.2

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

426

561

5.75

198.64

3.7

2.1

g/l

0.0

0.84

380

518

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

427

576

5.61

194.35

3.5

2.1

g/l

36.5

38.2

4.48

363

504

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

6950

39857

2.10

192.62

5.5

3.4

mu/l

1.9

2.4

2.87

6473

36274

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

572

1016

4.31

191.33

8.5

4.5

1.8

1.7

0.75

530

944

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

334

352

7.13

190.67

1.2

1.0

titre

111.4

64.0

—

(3021901) Oxygen saturation in Capillary blood

341

369

6.95

190.36

3.9

2.6

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

601

1116

4.13

190.03

2.6

1.6

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

3194

14116

1.99

187.85

5.9

2.5

—

(3003327) Ova and parasites identified in Stool by Light microscopy

613

1172

4.01

186.53

1.9

1.7

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

922

2331

3.09

185.24

1.5

1.2

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

459

695

5.01

184.94

1.8

2.2

mg/l

12.4

10.5

3.37

416

661

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

356

418

6.41

184.93

1.3

1.2

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

557

998

4.26

184.19

8.8

4.5

0.9

0.31

517

929

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

363

438

6.24

183.91

2.5

—

(3024928) Oxygen saturation in Venous blood

418

585

5.40

183.15

6.6

3.0

—

(3047181) Lactate [Moles/volume] in Blood

491

800

4.67

182.07

9.2

5.3

mmol/l

1.3

0.26

431

702

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

389

515

5.70

180.28

3.6

2.1

g/l

0.0

0.50

345

475

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

384

511

5.67

177.03

3.7

2.2

g/l

0.0

0.00

344

475

(3029937) Albumin [Presence] in Urine by Test strip

2269

9017

2.11

176.20

6.3

2.6

estimate

0.0

1.60

816

2974

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

244

188

9.68

175.92

3.3

2.4

e6/l

713.9

515.2

2.64

205

150

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

258

218

8.84

174.60

3.2

2.7

e6/l

599.3

588.9

0.04

111

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

5655

30705

1.89

173.71

5.3

2.4

u/l

64.7

41.2

33.77

5351

28894

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

138

37.78

173.32

5.9

6.2

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

238

181

9.80

173.07

3.4

2.5

e9/l

0.2

0.42

205

147

(3019150) Specific gravity of Urine by Refractometry

1910

7144

2.20

172.47

5.7

2.5

kg/l

1.0

0.47

319

1113

(3023419) Bacteria identified in Sputum by Culture

278

265

7.85

171.99

3.5

2.4

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

818

2016

3.15

170.96

1.6

1.4

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

232

173

9.99

170.87

7.6

1.8

nmol/l

1.0

0.8

2.18

196

163

(3008757) Leukocyte morphology finding [Identifier] in Blood

285

289

7.38

167.85

5.6

3.5

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

251

216

8.67

167.63

3.9

2.4

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

248

211

8.77

166.98

3.0

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

248

211

8.77

166.98

3.0

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

248

211

8.77

166.98

3.0

1.7

—

(3037121) Protein [Mass/volume] in Urine

544

1033

4.01

166.71

4.6

3.6

g/l

0.3

0.2

4.45

318

541

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

168

17.29

165.62

1.5

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

182

13.78

161.50

1.5

1.4

—

(3018405) Lactate [Moles/volume] in Arterial blood

438

724

4.58

159.46

6.0

3.4

mmol/l

1.4

0.09

433

716

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

576

1184

3.71

158.33

1.6

1.3

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

383

569

5.07

157.31

2.8

2.0

g/l

123.5

131.8

5.71

279

430

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

542

1096

3.76

152.34

3.5

2.3

90.3

88.7

0.59

517

1024

(3036489) Thrombin time

549

1124

3.72

151.64

3.3

2.0

22.0

21.6

0.69

499

986

(3042631) Mycobacterium sp identified in Specimen

297

356

6.25

151.23

4.2

2.6

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

245

237

7.71

149.77

1.3

1.2

—

(3020891) Body temperature

471

872

4.09

148.95

8.8

3.8

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

352

510

5.19

148.47

2.5

1.7

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

347

497

5.25

148.16

2.6

titre

10.2

16.3

—

(3024932) HLA-DR beta [Type]

173

100

12.82

147.95

1.1

1.2

—

(40767503) Oxygen content in Capillary blood by calculation

341

483

5.30

147.31

3.7

2.0

15.7

16.5

2.09

200

218

(3024471) HLA-A [Type]

174

103

12.52

146.91

1.0

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

257

273

7.02

145.56

5.1

3.8

57.7

56.9

0.14

181

174

(21494815) CD4 cells/100 lymphocytes in Specimen

265

293

6.75

145.03

2.9

2.1

35.8

36.5

0.06

(3044889) 12 lead EKG panel

5331

29360

1.77

142.77

4.8

2.8

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

304

398

5.72

142.24

1.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

6778

40166

1.87

141.36

7.2

2.9

mmol/mol

40.4

36.4

190.60

6350

36839

(3052851) Hemolysis interference index of Serum or Plasma

456

860

4.01

140.68

5.3

2.8

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

226

215

7.82

139.95

2.6

1.8

12.9

13.5

0.16

109

117

(3007566) Smooth muscle Ab [Titer] in Serum

462

887

3.94

139.18

1.3

1.4

titre

110.0

205.7

0.62

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

889

2569

2.68

138.99

4.3

2.3

ml/min/173m2

55.1

70.6

20.11

414

853

(3003181) Sodium [Moles/volume] in Urine

291

374

5.82

138.64

1.9

1.3

mmol/l

58.1

62.9

0.78

240

280

(3012501) Base excess in Blood by calculation

346

529

4.91

137.57

7.6

2.9

mmol/l

2.4

2.5

0.24

241

344

(3013290) Carbon dioxide [Partial pressure] in Blood

346

529

4.91

137.57

7.6

2.9

kpa

4.9

0.47

334

519

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

242

256

7.04

137.53

1.5

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

154

13.89

137.38

1.6

1.1

—

(3027315) Oxygen [Partial pressure] in Blood

347

533

4.89

137.26

7.6

2.9

kpa

8.8

0.12

335

523

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

219

206

7.91

136.80

2.5

1.9

—

(3034770) Mitochondria Ab [Titer] in Serum

451

863

3.95

136.44

1.3

titre

1008.6

1039.0

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

167

108

11.45

134.15

1.2

1.0

—

(3010421) pH of Blood

373

626

4.48

133.15

7.8

2.8

7.4

0.36

334

519

(3017732) Neutrophils [#/volume] in Blood

804

2257

2.75

132.61

3.9

2.5

e9/l

4.2

3.9

1.76

610

1813

(3030981) Hyaline casts [#/volume] in Urine by Automated count

666

1694

3.01

131.06

4.5

2.2

e6/l

0.2

0.3

0.95

650

1643

(3044927) Protein electrophoresis panel - Urine

176

129

10.11

131.00

1.2

1.1

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

332

512

4.86

130.70

1.3

1.1

u/ml

20.7

19.9

0.02

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

680

1756

2.97

130.35

2.5

2.3

au/ml

18.0

22.8

0.46

179

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

629

1555

3.09

129.84

1.3

1.2

au/ml

25.7

47.0

1.52

104

(3043409) Potassium [Moles/volume] in Arterial blood

365

615

4.46

129.65

6.4

3.7

mmol/l

3.8

3.9

0.22

341

585

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

161

104

11.46

129.41

3.8

2.5

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

304

439

5.18

128.58

1.6

g/l

0.7

0.8

0.99

217

334

(3010144) Erythrocytes [#/volume] in Synovial fluid

125

18.82

127.70

1.6

1.1

e6/l

211028.6

102008.0

0.46

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

62.20

127.37

12.5

7.6

mmol/l

4.9

4.3

0.62

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

131

16.67

127.30

1.5

1.1

—

(3018572) Chloride [Moles/volume] in Blood

346

569

4.56

126.49

10.6

6.3

mmol/l

105.0

105.2

0.29

310

506

(3039000) Anion gap in Blood

346

569

4.56

126.49

10.6

6.3

mmol/l

11.4

11.0

0.92

310

506

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

307

455

5.05

126.25

1.3

1.1

u/ml

4.0

5.7

0.26

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

475

999

3.60

125.94

4.0

2.1

206.9

186.2

4.33

447

953

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

264

346

5.69

123.33

1.3

1.1

u/ml

1.4

1.8

0.33

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

302

452

5.00

122.86

1.3

1.1

u/ml

3.4

2.4

0.58

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

642

1676

2.92

120.52

3.0

2.9

pmol/l

4.3

4.5

4.91

568

1485

(3014148) Varicella zoster virus Ab [Titer] in Serum

283

408

5.18

119.87

1.2

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

199

207

7.13

114.65

2.8

34.6

37.3

0.57

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

142

11.53

114.65

1.3

1.2

mmol/l

2.2

1.9

1.43

133

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

808

2460

2.53

112.99

9.8

3.1

mmol/l

1.2

3.51

752

2105

(3005322) IgE [Units/volume] in Serum or Plasma

718

2067

2.66

112.29

1.5

1.2

u/ml

234.8

288.6

0.75

646

1917

(3028271) Lactate [Moles/volume] in Capillary blood

260

368

5.27

112.27

2.8

1.5

mmol/l

1.5

1.7

1.92

254

361

(21494890) Protein electrophoresis panel - 24 hour Urine

181

176

7.62

110.14

3.3

2.3

—

(40768804) Tissue Pathology biopsy report

3603

18668

1.67

109.83

2.4

2.0

—

(3052592) Norovirus Ag [Presence] in Stool

23.50

109.53

1.7

1.4

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

160

134

8.83

108.86

1.2

1.1

iu/ml

3507.9

18.2

0.50

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

100

21.65

107.62

1.8

1.4

nmol/l

1.3

1.6

0.49

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

184

188

7.25

107.58

2.4

1.4

—

(3000093) Morphology [Interpretation] in Blood Narrative

213

258

6.13

107.31

1.2

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

301

506

4.45

107.10

1.1

1.2

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

7125

44181

1.77

107.10

28.2

8.4

ml/min/173m2

78.5

83.8

54.85

6136

34599

(3016018) Differential panel - Cerebral spinal fluid

169

156

8.02

107.07

1.7

1.3

—

(4062490)

203

234

6.44

107.01

1.6

1.2

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

267

408

4.88

106.10

1.3

—

(3017704) Immunofixation for Urine

131

11.37

105.00

2.0

1.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

166

155

7.93

104.25

3.7

1.9

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

119

13.29

103.94

4.4

3.6

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

199

233

6.34

103.43

1.6

1.2

g/l

0.4

0.18

139

157

(4010399)

718

2152

2.55

103.39

1.5

1.3

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

165

155

7.88

103.14

3.7

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

165

155

7.88

103.14

3.7

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

165

155

7.88

103.14

3.7

1.9

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

199

234

6.31

103.03

1.6

1.2

g/l

2.7

3.1

1.75

138

159

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

21.40

102.91

2.1

1.6

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

158

141

8.29

102.67

2.2

1.4

—

(3041096) Erythrocytes [Presence] in Urine by Automated

2262

10485

1.76

102.07

5.4

2.2

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

192

220

6.47

101.76

1.2

1.3

titre

270.0

54.3

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

198

235

6.25

101.64

1.6

1.2

g/l

6.7

6.8

0.16

136

159

(3004616) Nuclear Ab [Presence] in Serum

172

174

7.32

101.39

1.4

1.2

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

192

221

6.44

101.34

1.2

1.3

titre

194.2

258.3

0.32

(3028433) Virus identified in Specimen by Culture

126

11.20

100.10

1.4

1.2

—

(3032057) Clostridioides difficile [Presence] in Stool

100

17.11

98.35

2.7

1.8

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

273

455

4.47

98.12

7.8

2.5

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

239

359

4.95

96.78

1.4

1.2

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

311

582

3.99

96.65

1.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

241

366

4.90

96.41

3.2

2.8

nmol/l

0.9

0.8

1.45

177

274

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

100

16.00

95.52

1.9

1.2

30.3

33.0

0.17

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

172

187

6.81

95.45

1.2

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

105

14.31

95.24

1.2

1.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

18.19

94.81

1.4

1.6

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

163

169

7.13

94.16

1.5

1.3

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

163

169

7.13

94.16

1.5

1.3

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

151

143

7.80

93.80

1.1

1.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

140

121

8.54

93.13

4.0

2.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

100

15.02

92.81

3.5

2.6

—

(3008898) HLA-B27 [Presence]

309

596

3.87

92.22

1.1

1.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

138

119

8.56

91.95

4.0

2.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

138

119

8.56

91.95

4.0

2.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

105

13.33

91.90

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

145

134

7.99

91.78

1.2

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

141

126

8.26

91.53

2.3

1.4

—

(36660697) Celiac disease serology panel - Serum

811

2719

2.29

91.17

1.2

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

140

125

8.27

90.94

2.3

1.4

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

572

1653

2.62

88.28

2.6

2.3

—

(3051651) Icteric interference index of Serum or Plasma

171

204

6.20

87.37

6.1

3.5

—

(3004775) Volume in Urine collected for unspecified duration

104

11.26

82.98

3.0

1.7

709.5

710.3

0.00

(3009466) Valproate [Moles/volume] in Serum or Plasma

208

317

4.87

82.88

5.8

6.2

umol/l

359.3

400.7

3.20

188

274

(4146454)

13.18

82.72

2.5

1.4

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

298

606

3.67

82.64

1.2

1.1

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

115

9.52

82.60

1.1

iu/ml

3.7

3.3

—

(3023410) Appearance of Cerebral spinal fluid

137

135

7.49

82.49

2.1

1.5

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

14.70

80.89

1.6

1.0

—

(3003434) Protein [Mass/volume] in Pleural fluid

247

444

4.14

80.83

1.6

1.3

g/l

29.3

35.2

7.38

218

402

(21494434) Karyotype in Bone marrow

190

273

5.15

80.73

1.3

1.2

—

(3045142) Bone marrow Pathology biopsy report

230

391

4.37

80.69

1.6

1.4

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

400

999

3.00

80.60

1.4

1.1

—

(3045414) Leukocytes [Presence] in Urine

486

1353

2.71

80.52

2.5

1.6

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

119

102

8.60

79.64

1.1

1.0

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

352

821

3.21

79.41

1.3

1.2

—

(40761511) CBC panel - Blood by Automated count

7739

50356

1.75

79.23

30.1

7.6

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

218

365

4.43

77.90

1.2

1.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

181

257

5.21

77.88

6.2

2.6

mmol/l

7.5

6.1

5.26

149

219

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

12.97

77.73

1.8

1.0

u/l

6.2

4.9

0.89

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

166

219

5.60

77.02

2.5

1.6

mg/l

5.0

3.1

3.49

152

210

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

156

195

5.91

76.30

3.2

3.1

95.1

91.9

0.36

149

186

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

12.48

76.15

1.5

—

(3006245) CD3-CD19+ cells/100 cells in Blood

124

123

7.43

74.28

2.4

1.9

10.3

14.4

1.49

108

118

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

983

3840

1.97

73.90

12.8

4.6

—

(21494814) CD8 cells/100 lymphocytes in Specimen

111

8.51

73.82

2.6

1.8

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

126

131

7.09

72.64

1.4

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

118

114

7.62

72.19

4.4

2.5

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

115

108

7.84

71.92

1.3

1.1

u/ml

52.4

6.6

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

10.47

71.86

1.6

1.2

68.5

84.7

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

233

439

3.94

71.73

1.3

1.4

u/l

68.2

36.6

1.35

206

381

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

7897

52018

1.75

71.59

20.8

6.7

u/l

26.7

25.9

1.83

7727

49887

(3008295) Osmolality of Serum or Plasma

159

217

5.41

71.30

1.4

1.5

mosm/kgh2o

280.7

278.0

0.54

125

181

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

186

294

4.68

71.13

1.4

1.5

—

(3008037) Lactate [Moles/volume] in Venous blood

254

515

3.67

70.72

6.2

2.3

mmol/l

1.5

1.4

0.09

248

503

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

223

412

4.02

70.45

1.3

1.1

u/ml

43.0

26.3

0.76

(3038026) Centromere Ab [Units/volume] in Serum

115

111

7.63

70.41

1.3

1.1

u/ml

47.7

27.4

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

9.80

70.40

1.1

1.0

mg/l

394.6

225.4

1.16

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

9.51

69.72

1.2

1.1

mg/l

68.3

40.2

0.60

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1101

4559

1.86

69.30

4.7

3.4

32.2

0.06

823

2878

(4035726)

1067

4374

1.88

69.29

1.7

1.4

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

109

101

7.94

68.88

1.3

1.1

u/ml

2.1

2.2

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

112

108

7.63

68.63

2.9

3.5

au/ml

100.0

210.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

178

281

4.68

68.18

1.1

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

178

282

4.67

67.90

1.3

1.2

u/l

63.4

71.4

0.24

132

182

(3051611) Lipemic interference index of Serum or Plasma

196

338

4.29

67.58

6.1

2.9

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

7037

45210

1.57

67.51

5.4

3.1

mmol/l

6.0

5.5

146.76

6487

41537

(3023199) Leukocytes [#/volume] in Pleural fluid

217

407

3.95

67.21

1.6

1.4

e6/l

3371.8

3329.1

0.01

161

278

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

195

337

4.28

67.06

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

17.55

66.63

1.2

1.1

—

(3016750) Collection duration of Urine

10.31

65.91

3.3

1.7

min

478.1

503.8

0.73

(3038515) Glucose [Moles/volume] in Venous blood

239

488

3.64

65.88

6.2

2.4

mmol/l

7.4

6.4

7.41

234

478

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

130

159

6.03

64.93

1.6

2.2

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

130

159

6.03

64.93

1.6

2.2

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

118

130

6.68

64.78

3.6

4.2

mg/l

7.7

9.1

0.88

105

(3014271) Vancomycin [Susceptibility]

9.80

64.53

3.5

2.6

—

(3000330) Specific gravity of Urine by Test strip

494

1545

2.40

64.40

5.5

2.5

—

(3022621) pH of Urine by Test strip

634

2215

2.16

63.87

3.6

2.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1120

4776

1.81

63.84

3.7

5.0

ug/l

24.7

39.6

0.65

920

3834

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

9.68

63.33

1.1

1.0

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

15.35

62.89

2.5

1.2

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

108

111

7.16

62.88

6.6

5.7

mg/l

59.6

74.6

1.01

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

155

233

4.91

62.75

1.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

180

309

4.31

62.43

2.7

1.7

mg/l

31.4

32.5

0.07

(3006922) Hepatitis E virus Ab [Presence] in Serum

162

255

4.69

62.27

1.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

201

377

3.95

62.26

1.5

1.3

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

155

235

4.87

62.16

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

337

888

2.83

61.70

1.2

1.1

—

(21494755) Public health laboratory ask at order entry panel

460

7030

0.45

60.95

1.3

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

155

240

4.77

60.71

4.1

2.0

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

9.52

59.78

2.5

2.4

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

23.27

59.53

1.1

1.2

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2065

10513

1.56

59.39

1.9

1.5

mmol/l

1.5

1.3

16.83

1838

9014

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

199

384

3.84

59.35

1.4

1.2

u/ml

4.8

4.6

0.05

182

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

20.51

59.13

1.1

—

(3012441) Differential panel - Pleural fluid

190

357

3.94

58.73

1.5

1.4

—

(3049717) Cytology report of Urine Cyto stain

428

1307

2.45

58.67

2.8

2.9

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

211

431

3.63

58.15

1.6

1.1

iu/l

3.3

2.5

0.63

110

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

423

1295

2.45

57.67

1.1

u/ml

66.4

5.5

—

(3035637) Corticotropin [Mass/volume] in Plasma

203

407

3.69

57.44

1.6

1.5

—

(3006653) Thiamine [Moles/volume] in Blood

9.47

57.43

1.3

1.5

nmol/l

143.3

134.8

0.44

(3039162) Centromere protein B Ab [Units/volume] in Serum

144

220

4.83

57.27

1.4

1.1

u/ml

43.5

35.6

0.13

(3028308) Erythrocytes [#/volume] in Pleural fluid

194

378

3.80

57.11

1.6

1.4

e6/l

40156.1

34693.3

0.14

120

213

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

203

411

3.66

56.66

2.4

2.2

titre

2021.3

3095.0

0.26

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

22.40

56.61

1.1

1.2

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

19.78

56.26

1.2

1.1

—

(3016038) Potassium [Moles/volume] in Urine

115

144

5.88

56.20

1.7

1.1

mmol/l

28.8

40.8

4.35

103

128

(3000060) B lymphocytes [#/volume] in Blood

7.68

56.16

2.3

1.8

e6/l

2933.4

711.4

0.38

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

443

1403

2.37

56.09

1.8

1.7

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

13.58

55.77

1.1

1.0

u/l

1.0

0.40

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

166

293

4.18

55.64

1.4

1.2

u/l

326.5

588.2

1.39

154

285

(3036071) Salmonella sp Ab [Titer] in Serum

12.54

55.21

1.0

1.1

—

(4027681)

10.36

54.76

1.3

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

203

422

3.56

54.56

1.4

1.2

u/ml

2.9

2.3

0.41

160

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

7.79

54.29

1.5

1.3

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

211

461

3.39

52.69

1.1

g/l

1.6

1.5

2.05

186

429

(3011648) Oxygen content in Venous blood

150

255

4.34

52.69

5.3

2.9

10.5

11.3

1.31

150

255

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

8.69

52.14

1.1

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

115

156

5.42

51.95

1.3

u/l

106.3

104.7

0.04

100

140

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

102

124

6.05

51.29

1.4

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

102

124

6.05

51.29

1.4

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

102

124

6.05

51.29

1.4

1.1

—

(3024263) Appearance of Synovial fluid

10.18

51.17

3.0

1.2

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

5178

32071

1.40

51.04

3.5

2.9

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1123

5097

1.69

50.73

2.1

1.5

1.6

1.3

18.70

983

4609

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

111

149

5.48

50.69

1.3

u/l

29.5

24.6

0.36

130

(3045424) Erythrocytes [Presence] in Urine

222

514

3.20

50.66

2.0

1.4

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

21.50

50.44

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

101

124

5.99

50.32

1.4

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

101

124

5.99

50.32

1.4

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

101

124

5.99

50.32

1.4

1.1

—

(3002385) Erythrocyte distribution width [Ratio]

6274

40269

1.42

49.65

40.2

10.7

14.1

13.6

109.21

6195

39088

(3000492) Spirometry study

896

3841

1.77

49.50

1.7

1.4

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

7.34

49.45

2.3

1.8

—

(3019977) pH of Arterial blood

116

6.08

48.56

4.0

1.9

7.4

2.22

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

7.97

47.70

2.3

1.5

umol/l

122.9

116.4

0.06

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

100

129

5.70

47.52

5.9

3.8

—

(3020393) Adenovirus Ag [Presence] in Stool

10.99

47.34

1.6

1.5

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

134

227

4.35

47.30

1.4

1.2

u/l

18.3

12.9

1.58

120

217

(3036782) Glucose [Moles/volume] in Pleural fluid

165

328

3.71

47.29

1.5

1.3

mmol/l

6.8

5.4

5.24

150

301

(3017315) Amylase [Enzymatic activity/volume] in Urine

128

5.68

46.95

1.2

u/l

176.8

471.2

1.12

122

(40757373) Influenza virus identified in Isolate

9.30

46.87

2.0

1.4

—

(3036670) Protein [Mass/volume] in Synovial fluid

22.47

46.83

1.4

1.1

g/l

41.5

33.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

11.60

46.40

1.1

1.0

—

(40768806) Pleura Pathology biopsy report

175

368

3.51

46.30

1.5

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

83.55

45.87

2.1

2.6

umol/l

60.4

30.4

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

11.72

45.85

1.3

1.1

ng/l

1418.0

128.8

0.48

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

124

5.69

45.58

1.1

miu/ml

1546.0

1396.3

0.53

124

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

332

1021

2.42

44.78

1.4

1.3

—

(3048879) Bone marrow aspiration report

8.02

44.73

3.2

2.3

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

8.03

44.14

1.6

1.3

—

(3047189) Immunofixation for 24 hour Urine

100

6.24

44.09

2.8

2.0

—

(40768443) Skin Pathology biopsy report

443

1563

2.12

43.27

1.3

1.2

—

(3004451) EKG impression Narrative

6.52

43.19

1.4

1.2

—

(3045788) Cell count panel - Pleural fluid

161

336

3.53

43.09

1.7

1.4

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

7.23

43.04

2.6

mg/l

8.3

9.9

1.20

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

9.12

42.77

1.1

ng/l

375.4

1348.3

0.33

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

10.98

42.61

3.6

2.3

mg/l

34.2

11.1

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

10.69

41.92

3.9

3.1

mg/l

0.8

1.0

0.30

(3001964) Herpes simplex virus Ag [Presence] in Specimen

6.37

41.77

2.3

1.2

—

(4015189)

7.67

41.42

2.3

1.8

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

326

1033

2.35

41.17

1.1

u/ml

12.8

7.5

0.30

192

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

132

5.23

41.04

1.3

1.2

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

11.31

40.94

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

268

777

2.56

40.88

6.3

2.7

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

119

5.49

40.86

1.3

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

115

195

4.34

40.59

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2532

14279

1.40

40.57

4.6

4.7

ug/l

3.0

3.7

0.77

2283

13062

(3017569) Oxygen content in Arterial blood

6.54

40.07

3.3

1.9

—

(40761536) Microorganisms panel - Urine sediment

724

3099

1.76

39.89

7.2

2.7

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1541

7944

1.50

39.74

1.6

1.4

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

17.82

39.00

2.1

1.2

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

106

174

4.48

38.91

1.7

1.2

promille

1.0

1.6

3.44

135

(3011985) Renin [Units/volume] in Plasma

162

364

3.28

38.83

1.7

1.6

mu/l

93.1

61.5

0.64

141

328

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

482

6277

0.53

38.15

1.7

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

8.52

38.13

1.1

1.0

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

8.73

38.10

1.6

1.1

26.4

15.2

—

(3051593) INR in Capillary blood by Coagulation assay

7.71

37.26

7.6

19.2

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

6.90

36.92

2.1

2.3

u/l

39.6

73.1

0.42

(4268621)

136

282

3.55

36.79

2.4

2.2

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

14.63

36.71

1.2

1.0

—

(1761868) Lipid panel - Serum or Plasma

2110

19636

0.72

36.08

3.1

2.2

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

49.22

35.33

6.0

4.0

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

12.29

35.31

2.5

4.2

—

(4306422)

177

445

2.93

35.30

1.3

1.2

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

165

4.36

34.94

1.8

1.5

u/l

7.0

6.4

0.09

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

169

4.30

34.71

7.3

9.7

u/ml

45.1

10307.8

0.50

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

11.81

34.56

1.9

1.1

ug/min

125.1

8.1

0.97

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

150

346

3.19

34.54

1.3

1.2

nmol/l

0.6

0.42

141

333

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

149

343

3.20

34.42

1.3

1.2

nmol/l

0.3

0.1

0.40

(44816559) Phosphatidylethanol [Mass/volume] in Blood

206

572

2.66

34.26

1.5

1.3

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

9.90

34.08

1.1

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

114

222

3.77

33.72

1.1

1.0

mg/l

289.2

292.3

0.16

101

207

(3025315) Body weight

15.99

33.43

4.9

2.8

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

7.32

33.42

2.1

au/ml

85.7

86.6

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

132

288

3.37

33.16

1.4

1.2

nmol/l

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

16.57

32.97

1.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

435

1684

1.93

32.89

3.5

4.1

u/ml

1200.8

1767.6

0.22

366

1468

(40768441) Liver Pathology biopsy report

135

301

3.30

32.81

2.3

1.3

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

167

424

2.90

32.77

1.2

1.1

119.0

112.4

1.33

156

377

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

139

317

3.23

32.61

1.2

1.1

92.1

94.5

0.40

130

295

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

173

4.12

32.23

1.5

1.4

u/ml

21.9

19.1

0.21

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

6.55

32.07

1.2

1.3

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

120

252

3.50

31.92

1.2

1.1

—

(40757494) Bilirubin.total [Moles/volume] in Blood

109

5.04

31.64

3.3

2.0

umol/l

15.0

53.9

—

(3035880) pH of Pleural fluid

170

4.10

31.44

1.4

1.2

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

10.83

31.32

1.3

ug/l

0.4

0.5

0.25

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

16.70

31.13

3.0

5.5

—

(3006576) Bicarbonate [Moles/volume] in Blood

101

5.15

30.65

6.6

7.3

mmol/l

24.5

25.5

0.99

(3023487) Leukocytes [#/volume] in Peritoneal fluid

145

4.35

30.65

2.7

1.4

e6/l

5194.1

1362.1

0.44

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

7.63

30.23

2.6

3.2

—

(3002256) Pathology report gross observation

1200

6186

1.47

30.23

1.4

1.3

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

5.21

30.17

1.6

1.3

62.1

58.5

0.31

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

6821

45709

1.34

29.90

4.7

3.0

mmol/l

1.4

1.2

62.07

6305

42297

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

133

313

3.13

29.71

1.4

1.2

—

(3016244) Insulin [Units/volume] in Serum or Plasma

175

3.94

29.58

3.3

3.7

mu/l

24.9

27.1

0.14

167

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

125

4.58

29.53

2.6

1.4

e6/l

13468.7

6473.8

0.40

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

16.86

29.29

2.9

5.0

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

311

1113

2.07

29.27

1.5

1.4

u/l

10.4

10.5

0.06

257

896

(3044242) Glucose [Moles/volume] in Arterial blood

5.17

29.04

3.9

1.7

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

139

341

3.00

28.98

1.4

pmol/l

410.0

310.2

0.47

104

262

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

5.39

28.97

1.0

1.1

nmol/l

0.4

2.3

0.55

(3014051) Protein [Presence] in Urine by Test strip

220

687

2.37

28.77

3.0

1.7

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

167

456

2.70

28.74

1.2

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

5.51

28.28

14.5

7.9

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

133

4.35

28.23

2.2

1.5

168.6

132.8

2.16

126

(3009871) Measles virus Ab [Titer] in Serum

130

4.40

28.22

1.7

1.6

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

5.45

27.94

1.3

1.2

113.3

102.8

0.73

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

114

254

3.30

27.80

3.1

1.7

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

12.99

27.69

1.7

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

151

4.08

27.68

3.5

1.7

mg/l

183.2

24.4

2.08

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

566

2504

1.69

27.51

1.2

1.1

iu/ml

123.8

156.4

0.94

170

978

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

17.04

27.44

1.1

1.2

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

6.53

27.18

1.6

1.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

319

4267

0.53

27.16

1.5

1.4

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

5.36

27.03

1.7

1.1

g/l

12.5

0.01

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

17.93

27.00

1.1

1.3

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

12.31

26.92

1.3

1.2

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

5.44

26.57

1.3

1.1

88.1

91.6

0.20

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

11.69

26.18

1.3

ml/s/173m2

1.1

1.5

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

16.43

26.05

1.1

1.2

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

107

239

3.29

26.02

1.5

umol/l

14.4

11.7

2.49

102

226

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

6.61

25.83

1.7

1.4

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

9.40

25.81

1.2

1.3

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

6.29

25.76

1.4

1.2

23.4

21.4

0.15

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

7177

48789

1.32

25.40

5.5

3.5

mmol/l

2.6

3.0

196.15

6659

45111

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

13.24

25.33

1.4

1.8

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

13.24

25.33

1.7

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

8.42

25.26

1.0

1.1

—

(4212803)

10.63

24.78

1.2

1.0

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

5.09

24.38

1.3

1.1

85.2

94.1

0.81

(40761539) Cells [Type] in Urine sediment by Light microscopy

5.65

24.29

1.5

1.1

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

5.72

24.07

4.4

1.9

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

5.72

24.07

4.5

1.9

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

5.27

23.96

15.4

6.7

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

478

2103

1.69

23.69

1.1

1.0

—

(4024509)

109

262

3.05

23.60

1.8

1.5

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

203

3.36

23.46

1.2

1.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

234

821

2.10

23.26

3.2

4.1

u/ml

622.6

1185.0

0.49

208

752

(3033799) Differential panel - Peritoneal fluid

116

4.23

23.20

2.2

1.5

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

8.57

22.89

4.9

1.8

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

214

732

2.16

22.69

1.5

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

5.38

22.68

1.2

1.0

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

100

234

3.14

22.64

1.5

1.2

u/ml

1.6

1.3

0.09

103

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

169

525

2.37

22.45

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

129

352

2.69

22.33

1.5

1.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

171

540

2.33

21.91

1.3

1.2

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

7050

48082

1.29

21.89

5.1

3.3

mmol/l

4.5

4.9

176.06

6570

44779

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

8.01

21.82

3.2

2.9

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

162

504

2.37

21.47

1.9

2.1

ug/l

19.1

24.4

1.02

155

491

(3017446) Testosterone [Moles/volume] in Serum or Plasma

665

3251

1.53

21.33

2.3

1.9

nmol/l

12.1

13.3

2.95

583

2960

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

7.76

21.31

1.2

1.1

nmol/l

154.9

96.6

0.92

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

13.48

21.12

2.1

1.2

—

(3045716) Anion gap in Serum or Plasma

4.52

20.69

4.5

2.0

mmol/l

8.6

8.8

0.13

(3018851) Theophylline [Moles/volume] in Serum or Plasma

10.38

20.60

2.3

1.6

umol/l

48.4

44.8

0.17

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

6992

47752

1.28

20.49

5.0

3.3

mmol/l

1.4

1.5

85.17

6484

44363

(3009542) Hematocrit [Volume Fraction] of Blood

6845

46630

1.27

20.46

34.5

9.3

37.9

40.4

78.25

4762

37345

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

7.31

20.34

1.1

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

4.64

20.16

1.7

1.3

3.4

2.8

0.15

(3014891) Appearance of Pleural fluid

6.91

20.01

1.7

1.4

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

9.29

19.93

1.9

1.5

mg/l

1.7

5.5

1.08

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

156

3.47

19.73

1.6

1.7

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

4.46

19.62

1.6

1.1

g/l

23.5

27.1

0.67

(3034426) Prothrombin time (PT)

4.53

19.61

1.3

1.2

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

108

4.00

19.11

1.1

u/ml

4.6

3.0

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

4.42

19.09

1.0

ng/l

39.0

33.5

0.48

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

4.42

19.09

1.0

ng/l

282.7

310.1

0.31

(3036603) Volume of Urine

193

3.15

19.05

2.2

1.5

1784.0

2315.7

1.05

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

5.24

19.04

1.6

1.1

90.3

79.4

0.61

(3028707) Methadone [Presence] in Urine by Screen method

172

579

2.19

19.04

3.1

2.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

102

268

2.79

19.01

1.9

1.7

u/field

2.6

1.3

1.13

112

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

146

460

2.33

18.87

3.1

3.7

nmol/l

11.1

5.0

1.32

136

450

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

4.37

18.83

1.0

ng/l

748.7

799.2

0.30

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

137

420

2.40

18.80

1.4

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

175

597

2.16

18.75

1.1

au/ml

31.5

14.0

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

4.62

18.54

1.3

1.0

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

6.24

18.33

1.6

1.3

16.2

17.5

0.07

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

7.56

17.83

1.4

1.0

u/l

1231.5

41.1

0.47

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

4.52

17.73

2.6

2.8

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

8.63

17.60

2.0

1.5

mg/l

2.3

2.5

0.04

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

8.63

17.60

2.0

1.5

mg/l

2.9

0.7

0.75

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

8.63

17.60

2.0

1.5

mg/l

5.3

3.2

0.50

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

8.63

17.60

2.0

1.5

mg/l

4.7

3.0

0.31

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

8.63

17.60

2.0

1.5

mg/l

5.3

3.7

0.42

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

8.63

17.60

2.0

1.5

mg/l

3.2

4.7

0.28

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

8.63

17.60

2.0

1.5

mg/l

0.7

7.1

1.52

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

8.63

17.60

2.0

1.5

mg/l

3.0

3.6

0.13

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

8.63

17.60

2.0

1.5

mg/l

2.1

3.5

0.30

(3003694) ABO and Rh group [Type] in Blood

2245

13705

1.26

17.54

1.5

1.4

—

(3006270) Folate [Moles/volume] in Blood

227

2.87

17.52

1.2

1.1

nmol/l

332.4

387.7

1.63

209

(3004446) Plasmodium sp identified in Blood by Light microscopy

5.72

17.41

2.5

2.8

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

21.91

17.31

1.0

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

11.79

17.22

1.1

1.4

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

10.71

17.09

1.9

1.1

—

(3011436) Histone Ab [Units/volume] in Serum

7.06

16.89

1.1

1.0

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

4.96

16.74

1.3

1.1

86.7

67.0

0.98

(40758292) HTLV I+II Ab panel - Serum

4.30

16.71

1.7

1.4

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

149

3.29

16.55

1.1

u/l

109.3

83.2

0.82

121

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

149

3.29

16.55

1.1

u/l

43.8

18.6

1.47

116

(3007461) Platelets [#/volume] in Blood

8059

56424

1.32

16.48

48.0

12.0

e9/l

251.7

251.4

0.16

7926

54110

(3045462) Protein/Creatinine [Ratio] in Urine

5.88

16.40

8.0

2.7

g/mol

30.6

59.3

0.77

(3006462) Nitrate [Presence] in Urine

158

3.20

16.29

3.5

2.4

—

(3023511) Choriogonadotropin [Units/volume] in Urine

185

686

1.98

15.98

1.4

1.2

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

4.35

15.88

5.0

7.2

u/l

29.7

80.0

0.72

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

4.43

15.86

2.0

1.3

—

(3008402) Methanol [Moles/volume] in Serum or Plasma

8.84

15.83

1.1

mmol/l

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

9.45

15.82

1.0

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

9.45

15.82

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

9.45

15.82

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

9.45

15.82

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

9.45

15.82

1.0

1.1

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

9.45

15.82

1.0

u/ml

7.1

—

(3035941) MCH [Entitic mass]

8062

56507

1.32

15.74

47.7

11.9

30.2

0.07

7971

55344

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

4.29

15.63

1.1

1.2

—

(3036525) Urea [Moles/time] in 24 hour Urine

32.11

15.57

3.7

3.0

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

194

2.91

15.54

1.8

1.5

u/field

2.4

0.03

136

(3024731) MCV [Entitic volume]

8062

56535

1.31

15.39

47.8

11.9

91.3

90.5

39.51

7972

55369

(3026361) Erythrocytes [#/volume] in Blood

8062

56540

1.31

15.33

48.0

12.0

e12/l

4.3

4.6

263.13

7914

54075

(3010813) Leukocytes [#/volume] in Blood

8063

56548

1.31

15.33

48.1

12.0

e9/l

7.1

6.4

65.51

7913

54043

(3021387) Prolactin [Units/volume] in Serum or Plasma

319

1417

1.66

15.32

1.7

1.6

mu/l

348.6

323.6

0.27

293

1287

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

5.11

15.17

1.2

1.3

pmol/l

329.0

334.5

0.02

(3000963) Hemoglobin [Mass/volume] in Blood

8065

56585

1.31

15.07

48.3

12.0

g/l

129.5

137.4

307.65

7978

55413

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

6.39

15.01

1.2

1.3

nmol/l

7.4

242315.9

0.49

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

160

3.06

14.82

1.2

ratio

1.1

0.24

(3019768) Coxiella burnetii Ab [Presence] in Serum

10.66

14.71

1.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

10.66

14.71

4.8

6.3

—

(3044007) Cell count panel - Peritoneal fluid

120

3.41

14.67

2.7

1.5

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

4.14

14.63

1.9

1.3

24.0

0.00

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1917

11713

1.24

14.43

4.1

3.9

22.0

21.1

1.65

859

5790

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

175

2.93

14.35

1.1

1.3

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

10.94

14.13

33.4

3.3

—

(3024869) Neuronal Ab [Presence] in Serum

8.51

14.08

1.1

1.0

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

8.51

14.08

1.0

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

3.87

14.07

1.3

1.2

ug/l

80.8

316.0

0.84

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

5.72

14.07

1.1

1.0

—

(3035320) C reactive protein [Mass/volume] in Body fluid

222

2.67

14.07

3.5

2.2

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

9.90

14.06

1.1

1.4

—

(3036048) Francisella tularensis Ab [Titer] in Serum

3.73

14.02

1.1

1.2

—

1571.4

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

258

2.53

13.86

1.2

1.4

mmol/l

11.1

9.8

0.26

(40765096) Chromosome analysis panel by Banding

104

3.52

13.70

1.4

1.2

—

(3000012) Reticulocyte production index

153

3.01

13.59

1.5

—

(4211845)

181

2.83

13.55

3.6

2.3

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

319

1465

1.61

13.47

2.4

2.3

u/l

6903.3

6450.4

0.07

100

611

(1002224) Polysomnography panel

289

1301

1.64

13.23

1.0

1.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

108

351

2.26

13.14

1.8

1.6

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

244

1053

1.71

13.10

1.8

1.6

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

153

2.96

13.03

1.1

1.3

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

173

2.83

13.02

1.6

1.7

ug/l

7.1

8.7

0.60

157

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

806

4460

1.35

13.00

1.7

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

20.85

12.79

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

840

4693

1.33

12.70

1.8

1.7

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

106

347

2.24

12.70

1.1

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

4.55

12.62

1.2

titre

132.0

501.3

—

(3050794) Legionella sp Ab [Presence] in Serum

6.46

12.46

1.3

1.2

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

7.68

12.45

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

247

1085

1.68

12.45

1.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

315

1472

1.58

12.40

1.2

1.3

miu/ml

217.7

230.0

0.19

103

709

(3042517) Benzodiazepines panel - Urine

8.15

12.35

1.9

3.5

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

8.15

12.35

1.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

26.29

12.27

4.4

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

6.04

12.26

1.2

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

113

3.23

12.15

3.6

2.0

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

4.76

12.09

1.0

1.1

umol/24h

0.6

0.7

0.65

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

3.70

11.83

1.1

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

5.53

11.76

1.0

1.2

u/ml

27.3

20.3

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

5.53

11.76

1.0

1.2

u/ml

49.8

35.8

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

9.73

11.69

1.0

1.2

—

(44806420)

6.66

11.68

2.0

1.5

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

5.27

11.67

4.8

3.9

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

4.23

11.60

1.3

1.1

mmol/l

1.3

2.2

2.81

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

163

648

1.85

11.59

1.1

u/ml

3.1

2.9

0.08

381

(3037556) Urate [Mass/volume] in Serum or Plasma

3.92

11.53

1.7

1.3

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

6.18

11.47

2.7

2.3

umol/l

15.7

13.3

0.39

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

5.60

10.95

2.7

2.0

55.9

56.0

0.00

(46236302) HLA-C [Type] by High resolution typing

6.93

10.92

1.0

1.1

—

(40760409) HLA-A [Type] by High resolution

6.93

10.92

1.0

1.1

—

(40760410) HLA-B [Type] by High resolution

6.93

10.92

1.0

1.1

—

(3013862) HLA-DP [Type]

6.93

10.92

1.0

1.1

—

(40763590) HLA-DQ beta [Type]

6.93

10.92

1.0

1.1

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

3.31

10.85

2.0

1.5

nmol/l

5.4

4.9

0.06

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

4.87

10.75

1.6

1.1

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

4.87

10.75

1.3

1.1

u/l

20.2

19.4

0.05

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

4.41

10.74

1.4

1.5

—

(3030313) Adrenal Ab [Titer] in Serum

5.73

10.72

1.4

1.1

—

(4198724)

147

2.79

10.64

1.6

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

8.34

10.56

1.0

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

4.04

10.34

1.9

1.5

ug/l

9.3

9.4

0.04

(3013945) Hepatitis B virus e Ab [Presence] in Serum

6.91

10.32

1.1

—

(37021550) Renin [Units/volume] in Plasma --upright

4.35

10.21

1.3

1.5

mu/l

363.7

61.2

0.52

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

7.29

10.17

1.0

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

231

2597

0.64

9.99

1.5

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

8.42

9.95

1.1

1.0

—

(3020491) Glucose [Moles/volume] in Blood

228

2.34

9.84

2.2

1.5

mmol/l

7.9

5.7

4.28

177

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

6.89

9.72

1.0

—

(3002619) Bacteria identified in Specimen by Culture

3.84

9.68

1.3

1.2

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

136

2.74

9.46

1.6

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

137

555

1.81

9.27

2.3

2.6

umol/l

10.2

8.5

0.28

105

414

(3022689) Creatine [Moles/volume] in Urine

4.11

9.21

2.4

1.5

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

5.97

9.11

1.2

1.1

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

15.63

8.91

1.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

6.20

8.90

1.2

—

(40768795) Lymph node Pathology biopsy report

128

516

1.82

8.82

1.3

1.2

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

8.62

8.75

1.2

2.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

274

2893

0.68

8.72

1.7

1.6

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

102

2.94

8.62

1.2

1.3

g/l

0.3

0.85

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

160

696

1.69

8.51

2.0

1.7

pmol/l

189.6

213.0

2.25

153

666

(3035933) Granulocytes/100 leukocytes in Blood

141

2.59

8.39

1.4

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

231

2.22

8.38

1.0

—

(4034850)

239

1153

1.52

8.31

11.7

6.0

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

3.48

8.23

6.2

7.3

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

815

4810

1.26

8.07

2.1

1.9

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

909

5437

1.24

8.00

2.2

2.0

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

234

1135

1.51

7.95

1.7

1.5

nmol/l

41.0

43.6

0.79

228

1119

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

5.84

7.94

1.0

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

192

893

1.58

7.87

4.5

2.4

mg/l

36.1

28.3

1.57

131

554

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

6.08

7.72

3.0

2.3

—

(3040893) Potassium [Moles/volume] in Capillary blood

7.95

7.63

3.3

2.8

mmol/l

4.5

0.17

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

6.38

7.51

1.2

1.1

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

3.90

7.40

1.5

1.0

mmol/l

0.5

0.9

0.40

(3029075) Extractable nuclear Ab panel - Serum

3.01

7.30

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

3.73

7.27

1.5

1.4

—

(3041672) Baker's yeast Ab [Presence] in Serum

4.96

7.21

1.0

1.1

—

(44806071)

4.47

7.21

1.2

1.1

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

7.29

7.15

2.9

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

6.01

7.13

2.4

2.0

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

11.85

7.04

1.0

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

11.85

7.04

6.0

8.3

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

3.51

6.99

1.1

1.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

148

1690

0.63

6.98

1.5

1.4

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

133

584

1.67

6.91

1.4

1.3

u/l

28.4

32.2

0.56

110

490

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

207

2.15

6.90

3.2

2.1

u/l

218.2

209.2

0.25

207

(40763480) Human metapneumovirus Ag [Presence] in Specimen

5.67

6.77

2.7

1.2

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

6.73

6.72

3.6

1.3

—

(3009677) Dengue virus Ab [Presence] in Serum

6.73

6.72

1.1

1.2

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

12.50

6.68

1.0

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

170

804

1.55

6.56

1.7

1.5

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

905

0.52

6.51

1.4

1.5

—

(3043410) Blood group antigens tested for on Red Blood Cells

2.80

6.48

2.2

1.7

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1059

0.56

6.37

1.8

—

(3011288) Drugs identified in Urine by Screen method

220

1111

1.45

6.22

4.3

1.9

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

3.65

6.22

1.0

1.1

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

3.30

6.18

1.3

1.8

pmol/l

32.0

26.6

0.22

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

227

2.03

6.16

1.1

1.0

iu/ml

9.2

9.4

0.02

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

437

2479

1.30

6.01

3.9

4.1

u/ml

60.1

57.5

0.09

417

2419

(3004347) Hepatitis D virus Ab [Presence] in Serum

14.58

5.96

1.0

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

2.58

5.94

1.1

1.3

117.3

108.4

0.92

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

3.29

5.89

1.7

1.6

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

4.56

5.83

2.4

1.7

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

203

2.05

5.77

1.4

1.2

—

(3039443) Prostate specific Ag panel - Serum or Plasma

1136

0.60

5.72

1.4

1.6

—

(44813793)

225

1.98

5.63

1.0

1.1

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

12.15

5.58

1.1

1.2

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

4.38

5.57

4.2

7.4

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

4.64

5.55

1.0

1.2

umol/24h

1.8

1.5

0.46

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

101

1189

0.61

5.53

1.4

1.6

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

413

2353

1.29

5.52

2.0

1.8

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

+∞

5.51

1.2

0.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

131

2.29

5.42

1.8

1.1

—

(3046861) Legionella sp Ag [Presence] in Urine

5.73

5.36

1.1

1.0

—

(3003338) MCHC [Mass/volume]

6218

43667

1.11

5.30

41.7

10.5

g/l

330.8

333.1

68.28

6161

43257

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

4.74

5.27

1.3

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

140

1518

0.67

5.26

1.5

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

10.42

5.25

1.1

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.61

5.22

1.9

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.61

5.22

1.9

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.61

5.22

1.9

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

4.05

5.10

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

258

1391

1.36

5.10

2.5

1.6

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

5.35

5.03

14.6

7.9

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

108

1219

0.64

4.95

1.5

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

9.11

4.94

1.0

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

397

2293

1.27

4.81

1.5

1.3

iu/l

26.4

32.1

2.45

325

1955

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

3.37

4.80

1.0

1.1

—

(40768800) Prostate Pathology biopsy report

116

1278

0.66

4.76

1.2

—

(3051101) Glucose [Moles/volume] in Cord blood

5.01

4.72

5.4

1.6

—

(3002523) Influenza virus A Ag [Presence] in Specimen

162

818

1.45

4.69

1.3

1.1

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

3.44

4.69

2.8

1.4

mmol/l

7.0

6.2

0.43

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

155

2.07

4.66

1.5

1.3

umol/l

4.5

4.9

0.26

140

(3047352) Trisomy 18 risk [Likelihood] in Fetus

108

1199

0.65

4.61

1.4

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

119

566

1.54

4.61

1.6

1.4

—

(3010937) Rubella virus Ab [Presence] in Serum

3.93

4.59

1.1

1.0

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

127

2.18

4.58

1.1

87.3

94.7

0.78

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

134

1422

0.68

4.56

1.4

—

(3003740) Influenza virus B Ag [Presence] in Specimen

161

818

1.44

4.53

1.3

1.1

—

(3009992) Blasts/100 cells in Bone marrow

11.66

4.48

2.4

1.4

2.5

26.2

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

3.65

4.48

1.2

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

4.37

4.47

1.2

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

136

1433

0.69

4.47

1.4

—

(3005033) Fetal Nuchal fold Thickness US

108

1190

0.66

4.46

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

135

1424

0.69

4.46

1.4

—

(3013336) Amino acids [Identifier] in Serum or Plasma

5.21

4.45

3.9

2.6

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

136

1431

0.69

4.43

1.4

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

3.13

4.32

2.4

1.7

u/field

0.4

0.03

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

3.95

4.30

1.0

1.2

—

(3013293) Extractable nuclear Ab [Presence] in Serum

8.20

4.28

1.8

1.4

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

4.17

4.23

1.8

1.3

ng/l

279.8

174.3

0.57

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.40

4.21

1.4

—

(4094501)

198

1064

1.36

4.08

1.1

—

(3007919) Fasciola sp Ab [Titer] in Serum

8.33

3.88

1.0

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

199

1.83

3.82

1.2

1.3

—

(3016135) IgD [Mass/volume] in Serum

10.21

3.77

6.3

1.0

mg/l

26.2

26.6

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

493

3004

1.21

3.73

2.1

1.9

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

657

0.59

3.71

1.1

1.2

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

4.01

3.71

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

3.04

3.48

1.7

1.8

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

185

1.82

3.43

1.9

1.4

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

348

0.46

3.41

1.1

1.3

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

2.39

3.33

1.1

1.5

nmol/l

0.3

0.2

0.20

(3044009) aPTT.lupus sensitive (LA screen)

3.64

3.30

1.1

1.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

103

514

1.46

3.29

1.2

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

2.47

3.24

1.1

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

5.83

3.19

1.3

1.0

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

4.69

3.05

1.0

—

(3049242) von Willebrand panel - Platelet poor plasma

6.38

3.00

1.1

1.3

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

2.43

2.99

1.2

1.1

u/ml

0.1

0.0

0.18

(3025886) Oxalate [Mass/time] in 24 hour Urine

7.29

2.83

1.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

370

0.53

2.79

1.4

1.5

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

3.08

2.63

1.0

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

313

1.52

2.55

1.1

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

4.16

2.52

1.0

38.3

36.6

—

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

4.16

2.52

1.0

19.1

22.5

—

(3019174) dRVVT (LA screen)

3.17

2.49

1.1

1.2

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

236

1.58

2.40

1.3

1.1

—

(3016879) Cocaine [Presence] in Urine

291

1771

1.20

2.36

2.4

1.6

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

4.86

2.23

1.3

1.6

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

156

1.68

2.20

1.1

u/ml

3.9

13.4

—

(3001729) Color of Synovial fluid

6.07

2.20

2.0

1.5

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

163

1476

0.80

2.07

1.5

—

(3032641) Amino acids panel - Urine

5.20

2.01

1.4

1.1

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

5.20

2.01

1.2

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1312

8904

1.09

1.97

2.9

ug/l

0.8

1.16

891

5617

(3032868) Hemoglobin electrophoresis panel in Blood

2.19

1.95

1.5

1.6

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

2.07

1.93

1.1

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

1.93

0.0

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

488

0.67

1.92

1.0

1.1

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

3.40

1.91

1.0

—

(3049233) Organic acids panel - Urine

4.55

1.85

1.0

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

2.91

1.82

1.4

1.3

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.10

1.79

1.0

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

191

1.53

1.72

2.0

—

(3025549) Creatine [Moles/time] in 24 hour Urine

3.00

1.70

1.0

1.2

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

3.36

1.68

1.2

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

389

1.35

1.64

3.4

6.1

u/ml

245.2

67.9

0.56

138

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

130

1.63

2.7

ng/l

101.6

122.9

0.34

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.83

1.60

1.1

1.0

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

3.12

1.57

1.0

1.1

u/l

11.5

7.1

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

3.64

1.57

1.2

1.4

—

(3041806) Other cells [#/volume] in Blood by Manual count

200

0.55

1.55

2.1

1.4

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

110

996

0.80

1.49

3.9

3.3

u/ml

40.9

36.7

0.14

104

962

(3038385) Creatinine [Moles/volume] in Peritoneal fluid

2.91

1.47

2.7

1.5

umol/l

189.3

225.5

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.43

1.47

1.9

1.2

umol/24h

435.8

320.9

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

3.31

1.45

1.0

—

(3028300) Cannabinoids [Presence] in Urine

306

1964

1.14

1.40

2.4

1.5

—

(3000764) Benzodiazepines [Presence] in Urine

302

1946

1.13

1.32

2.4

1.5

—

(40768793) Breast Pathology biopsy report

146

1263

0.84

1.29

1.3

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

2.14

1.28

1.0

—

(3034614) HLA Ag [Interpretation]

2.80

1.24

1.0

1.1

—

(3027008) Opiates [Presence] in Urine

303

1965

1.13

1.22

2.4

1.5

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

287

0.68

1.15

2.1

1.9

—

(3011325) HIV 1+2 Ab [Presence] in Serum

2.43

1.14

1.0

—

(3022475) Manganese [Moles/volume] in Blood

2.05

1.06

1.2

1.3

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.79

1.06

12.1

5.2

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

105

1.53

1.03

2.2

1.7

—

(4133840)

120

1.46

0.93

1.2

1.1

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

2.19

0.92

3.2

1.2

nmol/l

15.6

34.2

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

117

727

1.17

0.92

1.7

1.4

nmol/l

0.2

0.4

4.00

101

570

(3017509) Phencyclidine [Presence] in Urine

1.78

0.90

1.4

1.1

—

(3025130) Human papilloma virus identified in Specimen

116

722

1.17

0.90

1.8

1.7

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.82

0.85

1.0

—

(4281824)

108

673

1.17

0.84

1.3

1.1

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

1.65

0.78

14.2

9.3

—

(3013762) Body weight Measured

1.82

0.78

1.0

1.3

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.68

0.75

1.0

1.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

338

0.80

0.66

1.1

u/ml

4.7

7.4

0.22

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

237

1872

0.92

0.61

1.5

1.4

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

266

2090

0.92

0.60

1.8

1.5

mg/l

7.0

2.5

3.49

209

1312

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1097

8274

0.96

0.60

1.5

1.4

—

(3020650) Glucose [Presence] in Urine

127

1.32

0.57

2.3

1.2

—

(3027944) Amphetamines [Presence] in Urine

287

1948

1.08

0.57

2.3

1.5

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

106

688

1.12

0.54

1.5

1.4

ug/l

3.7

5.5

0.57

598

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

715

5004

1.04

0.51

1.4

1.3

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

129

851

1.11

0.50

1.1

u/ml

1.0

2.6

1.73

221

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

348

0.84

0.49

1.4

1.6

mmol/l

8.2

7.4

0.98

218

(4038314)

1.46

0.47

1.3

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

1.33

0.46

1.1

u/ml

0.0

11.6

—

(3022670) pH of Venous cord blood

0.00

0.42

0.0

1.1

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

0.42

0.0

1.0

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.36

0.41

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

308

0.85

0.39

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

127

852

1.09

0.39

1.1

u/ml

0.5

1.7

2.50

385

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

278

1.15

0.37

4.7

7.9

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

617

1.10

0.36

1.2

1.3

mmol/l

7.2

6.5

1.35

433

(3003888) Timothy IgE Ab [Units/volume] in Serum

132

891

1.08

0.36

1.1

u/ml

3.2

6.3

2.17

470

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

420

0.88

0.35

1.4

1.2

pmol/l

53.0

72.1

0.59

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

145

984

1.07

0.35

1.1

u/ml

0.8

2.2

2.16

414

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

131

1.22

0.35

1.0

—

(3000285) Sodium [Moles/volume] in Blood

1.27

0.28

1.0

1.1

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.22

0.0

1.0

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.22

0.0

6.8

—

0.3

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.22

0.0

1.0

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

314

0.90

0.21

1.1

1.0

u/ml

0.2

3.0

—

(3015183) Erythrocyte sedimentation rate

210

1.11

0.19

1.2

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

105

728

1.05

0.17

1.1

u/ml

9.5

3.9

0.45

294

(3023430) Cat dander IgE Ab [Units/volume] in Serum

100

693

1.05

0.17

1.1

u/ml

2.5

3.9

0.56

285

(3012494) Peanut IgE Ab [Units/volume] in Serum

129

1.13

0.15

1.1

u/ml

0.2

11.8

1.08

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

214

1.09

0.14

1.5

1.9

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

165

1.10

0.14

2.6

2.5

nmol/l

166.5

159.3

0.11

147

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

177

0.91

0.13

6.6

6.5

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

177

0.91

0.13

3.3

3.2

—

(3001556) Androgen free Index in Serum or Plasma

1.10

0.10

3.4

1.2

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.84

0.08

1.2

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

250

1794

1.02

0.07

1.9

1.7

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

597

0.99

0.01

1.0

1.1

u/ml

0.5

0.9

0.39

136

(40765089) Chromosome analysis panel - Blood by G-banded

179

1.02

0.00

1.0

—

(3020874) Milk IgE Ab [Units/volume] in Serum

333

1.01

0.00

1.1

u/ml

2.5

3.4

0.13

(3029396) Erythrocyte agglutination [Presence] in Blood

122

1.01

0.00

1.9

3.0

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.87

0.00

1.2

1.1

—

(3027859) Formaldehyde IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

0.0

1.2

—

71.9

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: IBD_INFECTIONS – Infections, IBD-co-morbidities

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Infections, IBD-co-morbidities

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Infections, IBD-co-morbidities (IBD_INFECTIONS)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints